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SUMMARY 
 
 The biocompatibility and biodegradability of poly(lactic acid) (PLA) facilitate its 
use in a variety of biomedical applications, ranging from sutures to drug delivery. 
However, uncontrolled interactions with cells and insufficient mechanical properties have 
prevented PLA from reaching its full potential as a scaffold for use in tissue engineering. 
Methods to improve the mechanical, chemical and biological properties of PLA are 
limited by the lack of functional groups along the backbone of the polymer. One possible 
approach towards overcoming these limitations involves the incorporation of functional 
groups into the backbone of the polymer through the copolymerization of monomers 
bearing protected functional groups. Deprotection and modification of these functional 
groups could provide the opportunity to direct the attachment of cells, and enhance to the 
physical properties of the polymer. 
 We have developed a general methodology for the synthesis of lactide monomers 
substituted with protected functional groups (alcohols protected as benzyl ethers, amines 
protected as benzyl carbamates and carboxylic acids protected as benzyl esters). The 
monomers were homopolymerized, and copolymerized with lactide, and deprotected to 
give functional PLA copolymers with pendant hydroxyl, amine, and carboxyl groups.  
 A thorough investigation of the chemical modification of PLA copolymers 
bearing functional groups along the polymer backbone was performed on a copolymer 
prepared by copolymerizarion of a dibenzyloxy-substituted lactide monomer with lactide 
followed by reductive debenzylation. Reaction of the resulting hydroxyl-substited PLA 
with succinic anhydride resulted in an acid-substituted PLA that is amenable to standard 
 xxiii
EDC/NHS coupling. The utility of this copolymer was illustrated by coupling with an 
amine derivative of biotin, and an RGD-containing peptide sequence. The preparation of 
the biodegradable polyester substituted with RGD, a ubiquitous adhesion peptide, 
provided us with control over cellular attachment to the hybrid material. 
 We also explored approaches to make use of the pendant functional groups on 
PLA to enhance the physical properties of polymer foams. Copolymers with pendant 
photocrosslinkable cinnamate groups were prepared by reaction of the hydroxyl-substited 
PLA copolymers with cinnamoyl chloride. The copolymer was foamed using thermally-
induced phase separation (TIPS), and photocrosslinked upon irradiation at 300 nm. 
Irradiation resulted in an increase in the compressive modulus of the foams. Crosslinking 
also led to a decrease in the rate of hydrolytic degradation of the foams, thereby 
demonstrating the potential for use of these strategies in the development of porous 
scaffolds for bioengineering. 
 Another potential approach towards the preparation of robust polymer foams is 
the incorporation of a rigid polymer block which can phase separate during foam 
formation to provide additional structural integrity. Several poly(norbornene)-PLA 
diblock copolymer compositions were prepared by the ring-opening of lactide by a 
hydroxyl-terminated poly(norbornene) macroinitiator. The ability of the diblock 
copolymer to phase separate at elevated temperature was verified using small-angle x-ray 
scattering and wide-angle x-ray scattering.  
 1
CHAPTER 1 
INTRODUCTION TO POLY(LACTIDE) 
 
1.1. Biodegradable Polyesters 
 Plastics have become so integrated into our every day lives; worldwide 
production of plastics totaled more than 200 million metric tons in 2006.1  However, 
limited landfill space and the acceptance that crude oil is a surely limited resource have 
forced the consideration of alternative materials as a replacement for petroleum-based 
plastics.2 Of particular interest are biodegradable polymers, specifically linear aliphatic 
polyesters such as poly(lactide) (PLA), poly(glycolide) (PGA), and poly(ε-caprolactone) 
(PCL), Figure 1.1.3 These polymers contain ester functionalities throughout the backbone 
which facilitate rapid degradation in a landfill.4,5 Such polymers may also be employed as 
materials for medical applications in which they are hydrolyzed in vivo, and converted 
into non-toxic components that are excreted from the body.6,7 The attractive physical 
properties and biodegradable character of these polylactones have led to their use in a 
variety of applications ranging from plastic water bottles and food storage containers8 to 
biomedical devices such as sutures.9,10  
 
Figure 1.1. Examples of biodegradable polyesters. 
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1.2. PLA 
1.2.1. PLA Production 
 Poly(lactide), or PLA,  has emerged as an attractive biodegradable polyester due 
to its availability from annually renewable feed stocks. The starch-based constituents 
found in corn, wheat, potatoes, and food processing waste products can be converted into 
lactic acid by fermentation and used in the production of PLA, Figure 1.2.11 PLA is 
hydrolytically and oxidatively degraded into carbon-dioxide and water, where it can re-
enter the cycle.12 
 
Figure 1.2. A simplified view of the PLA life cycle. 
 
 In 1994, Cargill commenced operation of a small PLA development facility in 
Minnesota capable of producing 5,000 metric tons of PLA per annum. In 2004, Cargill-
Dow unveiled a full-scale PLA plant in Nebraska capable of producing 140,000 tons per 
year.13 The manufacture of PLA has not been limited to the United States, and the 
worldwide production of PLA is expected to reach nearly 400,000 metric tons in 2008.14 
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1.2.2. Methods for PLA Preparation 
 There are two main methods used in the production of PLA from lactic acid, 
Figure 1.3. The first route involves the step-growth polycondensation of lactic acid which 
requires high temperatures and results in the formation of lactic acid oligomers with 
maximum number average molecular weights usually on the order of 30 kg/mol.15 This 
process is often limited to the production of low to intermediate molecular weight 
polymers and can be plagued by side reactions due to excessive temperatures. However,  
Mitsui Toatsu Chemicals patented a polycondensation method which makes use of the 
azeotropic removal of water from the polymerization by distillation of a high-boiling 
solvent to give high molecular weight polymer.16 The other main strategy used for the 
synthesis of PLA involves the conversion of lactic acid to the corresponding cyclic dimer 
known as lactide.17 The lactide monomer undergoes a ring-opening polymerization under 
mild conditions with short reaction times to give high molecular weight PLA.18  
 
Figure 1.3. Two common approaches used to synthesize PLA. 
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 Cationic,19-21 anionic,22-24 and coordination-insertion25-27 mechanisms can all be 
used for the ring-opening polymerization of lactide using a variety of different catalysts. 
The most common catalyst by far is Sn(II) 2-ethylhexanoate (or stannous octanoate, 
abbreviated SnOct2) which has been used extensively in the preparation of high 
molecular weight PLA.28,29 Stannous octanoate is preferred due to its commercial 
availability, effectiveness, low rate of racemization of the lactide, and low toxicity. Its 
presence in PLA  is accepted by the United States Food and Drug Administration 
(FDA).30 
 
1.2.3. Applications of PLA 
 PLA exhibits a diverse range of properties depending on how it is processed. 
Using standard processing equipment, it can be molded into flexible films for use in 
plastic wrap and shrink labels, or woven into fibers for use in clothing and carpeting.14 
The biocompatible and bioassimilable nature of PLA allow the use of FDA-approved 
PLA-PGA copolymers in numerous biomedical applications, including orthopedic 
devices such as clips and bone pins, sutures, and controlled drug delivery matrices.31 All 
of these applications make use of the physical and biodegradable properties of PLA, 
which can be affected by the molecular weight, polydispersity, and tacticity of the 
polymer.9 However, PLA is not suited for many applications due to its brittleness, 
thermal instability, and hydrophobic properties.2  
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1.3. Overcoming the Limitations of PLA 
 Much work has focused on tailoring the bulk physical properties of PLA using 
methods such as incorporating other comonomers into the polymer backbone by ring-
opening copolymerization with lactide,32-36 the formation of diblock copolymers,37 
blending PLA with other polymers,38 and the addition of plasticizers39 or crosslinking 
agents.40,41 Recently, efforts have focused on incorporating functional groups directly into 
the polyester backbone of PLA by the copolymerization of protected functional 
monomers.42 Protected functional lactides,43-45 glycolides,46-49 esteramides,50-55 N-
carboxyanhydrides,56-59 and lactones60-64 have been copolymerized with lactide monomer 
to give random copolymers with pendant protected functional groups. Such functional 
groups could be used to alter the thermal properties of the polymer65,66 and thereby 
provide a means to attach drugs, control the rate of hydrolytic degradation, and to impart 
hydrophilicity.15 However, beyond the removal of the protecting group, these approaches 
have not been thoroughly investigated. 
 
1.4. Hybrid Scaffolds for Tissue Engineering 
 The field of tissue engineering has emerged as an attractive approach to repairing 
malfunctioning or lost organs.67 In tissue engineering, cells are seeded onto a 
biologically-modified porous temporary scaffold where they proliferate, secrete 
extracellular matrices, and promote the formation of tissue, Figure 1.4.68 The scaffold, 
which initially serves as a physical support to guide the formation of the new tissue, 
degrades and is ultimately eliminated from the body. Requirements for scaffolds for 
tissue engineering include high porosity to allow proper cell growth, biocompatibility, 
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biodegradability, and sufficient mechanical properties to prevent premature 
deformation.69,70 Two main types of scaffolds are generally used for tissue engineering; 
those fabricated from naturally derived polymers, such as collagen, and scaffolds made 
from synthetic biodegradable polyesters such as PLA.71 The poor mechanical properties 
of naturally derived polymers and the inability to control the interactions of cells with 
hydrophobic biodegradable polyesters have prompted the formation of third class of 
hybrid foams which combine both synthetic and natural materials.72 
 
Figure 1.4. One common approach towards tissue engineering. 
 
1.5. Scope of Work 
 Besides having the potential to improve the physical properties of the 
polymer,65,66 the incorporation of pendant functional groups onto the backbone of PLA 
could be used to enhance the material’s biocompatibility.15,49 The peptide sequence RGD 
(Arg-Gly-Asp) has been shown to improve the cellular attachment and cytocompatibility 
of a variety of materials.73,74 The attachment of biologically relevant motifs such as RGD 
to PLA could provide the opportunity to control cell adhesion and function.50 This 
combination of synthetic biodegradable polymers with peptides could be used to prepare 
novel biodegradable hybrid PLA scaffolds ideal for tissue engineering which have the 
ability to promote specific scaffold-cell interactions. 
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 In this thesis, I describe a series of studies directed towards the development of 
new PLA based scaffolds for tissue engineering, Figure 1.5.  
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Figure 1.5. Overview for the fabrication of a self-assembled peptide-immobilized PNb-
PLA diblock copolymer scaffold. 
 
 In Chapter 2, I describe the preparation of protected functional lactide monomers 
(this work was done in conjunction with Warren Gerhardt from Marcus Weck’s group 
who initially began our study of functional lactides), Figure 1.5. The monomers were 
homopolymerized and copolymerized with lactide. Subsequently deprotection gave 
functional PLA copolymers with pendant hydroxyl, amine, and carboxyl groups. We then 
focused our attention on the modification of functional copolymers with biological 
Chapter 3 Chapter 4 
Chapter 3 
Chapter 5 
Chapter 2 Chapter 3 
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ligands such as RGD. This modification increased the amount of cellular attachment to 
PLA copolymer films (Chapter 3). Having shown that we could use the pendant 
functionalities to alter the biological properties of PLA, we next focused on modifying 
the physical properties of PLA. Chapter 4 describes our efforts to enhance the mechanical 
properties of PLA films and foams through the attachment of photocrosslinkable groups 
to the backbone of PLA copolymers. We have also explored an alternative route towards 
the fabrication of scaffolds with enhanced mechanical properties through development of 
block copolymers whereby a rigid hydroxyl-terminated poly(norbornene) (PNb) is used 
as a macroinitiator for the ring-opening of lactide to give PNb-bl-PLA diblock 
copolymers (Chapter 5). Incorporation of the rigid PNb block provides the opportunity 
for self-assembly and added structural integrity. The information obtained regarding the 
tethering of peptides, the attachment of photocrosslinkable groups, and the incorporation 
of semi-rigid PNb blocks can ultimately be used to aid in the design of highly porous 
polymer scaffolds with enhanced mechanical and cellular properties.   
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CHAPTER 2 
SYNTHESIS OF NEW FUNCTIONAL PLA COPOLYMERS‡ 
 
2.1. Introduction 
 With the global production of poly(lactide) PLA expected to reach almost 
400,000 tonnes for the year 2008,1 its impact on the plastics industry is becoming more 
evident as time progresses.2 The biodegradable and biorenewable properties of PLA have 
contributed to its advancement in several major industries, including use in fibers and 
packaging,3 and its emerging use in biomedical applications such as implantation devices, 
sutures, tissue replacement, and as a delivery vehicle.4-6 However, PLA is not well suited 
for many applications due to its brittleness, hydrophobicity, and lack of pendant 
functional groups along the backbone of the polymer.7 The incorporation of functional 
groups would provide the means to control the physical properties of PLA, including its 
degradation rate,8 hydrophobicity,9,10 and thermal properties.11 Such functional groups 
could also be used to enhance the biocompatibility of PLA12,13 and could be used for the 
attachment biomolecules to control cell adhesion and function.14 
  The main method used for the incorporation of functional groups into the 
backbone of PLA involves the copolymerization of protected functional 
glycolides,9,10,13,15 esteramides,14,16-21 N-carboxyanhydrides,22-26 and lactones27-31 with 
lactide monomer. Kimura was the first to report on the synthesis of poly(glycolide) 
copolymers with pendant carboxylic groups based on the copolymerization and 
deprotection of a protected functional glycolide monomer (Figure 2.1).15 Other 
                                                 
‡ The work found in this Chapter was done in collaboration with Dr. Warren W. Gerhardt from the group of 
Dr. Marcus Weck and certain portions were published in Biomacromolecules 2006, 7, 1735-1742. 
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functionalized glycolide monomer derivatives followed,32 including one containing a 
protected gluconic acid sugar.33 However, poly(glycolide) displays greater hydrophilicity 
and undergoes more rapid degradation than PLA, which can limit its use in biomedical 
applications.34,35 Other comonomers include morpholine-2,5-dione derivatives (Figure 
2.1) which have been copolymerized with lactide to give poly(esteramides).14,16-21 
However, the dissimilar structures of the amide-containing monomers compared to 
lactide results in changes in the polymerization and degradation rates of the 
corresponding copolymers relative to PLA. 
 These differences in the properties of the functional poly(glycolide) and 
poly(esteramide) copolymers demonstrate the need to explore the prepatation of 
functional lactide monomers which will more closely resemble the structure of PLA 
when incorporated into a copolymer. In this work, we examine the synthesis, 
polymerization, and copolymerization of 6-methyl-1,4-dioxane-2,5-diones bearing a 
protected functional group at the 3 position that is subject to further modification (Figure 
2.1). Though extensive work has been done on the copolymerization of glycolide and 
morpholine-2,5-dione derivatives with lactide, there are only a few reports regarding the 
preparation of analogues of the lactide monomer.9,10,33,36 Baker37-40 and Möller41-44 have 
reported on the preparation and copolymerization of alkyl-substituted lactides (i.e., with 
alkyl substituents on the 3 position) as a method to alter the physical properties of PLA 
copolymers. However, the resulting copolymers lack the functional groups required for 
further modification. In an effort to explore the possible advantages of functional lactide 
copolymers, we have developed a novel strategy for the preparation and polymerization 
of functional lactide monomers derived from commercially available amino acids. This 
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methodology could potentially be used with a host of protected amino acid starting 
materials to provide an array of different protected lactide monomers. Preliminary data 
shows that the resulting protected lactide monomers can be successfully homo- and 
copolymerized with lactide to give PLA homo- and copolymers with pendant functional 
groups which might be used for post-polymerization modification with bioactive ligands.  
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Figure 2.1.  Functional lactide analogues. 
 
2.2. Experimental 
2.2.1. General Methods 
 H-Ser (Benzyl)-OH was purchased from Indofine Chemical Company.  H-Glu(O-
Benzyl)-OH was purchased from 3B Medical Systems.  H-Lys(Z)-OH was purchased 
from Fluka.  DL lactide was purchased form Aldrich and recrystallized (2x) from dry 
EtOAc, dissolved in dry benzene, frozen, lyophilized and stored in a nitrogen filled glove 
box prior to use.  N,N-Diisopropylethyl amine (DIEA), Et2O and benzene were distilled 
from sodium benzophenone ketyl solutions, EtOAc from CaH2, acetone from 4Å 
molecular sieves, and CH2Cl2 was dried via passage through Cu2O and alumina columns.  
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All anhydrous liquids brought into the nitrogen-filled glove box were first degassed with 
three freeze-pump-thaw cycles using liquid nitrogen at 50 mmHg. Chromatography was 
performed with Sorbent Tech Premium Grade silica: porosity 60 Å, particle size 40-75 
m (200×400 mesh), surface area 450-550 m2/g, pH range 6-8., decomposition of cyclic 
monomer 1 was observed during chromatography using Sorbent Tech Standard Grade 
silica: porosity 60 Å, particle size 32-63 m (230×450 mesh), surface area 500-600 m2/g, 
pH range 6.5-7.5.  Compounds were analyzed by use of UV light (254 nm), I2, or a 5% 
solution of ammonium molybdate in 2 M sulfuric acid.  IR spectra were recorded on a 
Schimadzu FT-IR-8400S.  Melting points were determined with a Mel-Temp II apparatus 
fitted with a Fluke 51K/J digital thermometer and are uncorrected.  Molecular weight data 
were collected on a Schimadzu GPC system consisting of a SCL-10Avp system 
controller, an LC-10ADvp pump, and a SPD-M10Avp diode array detector.  The eluant 
was methylene chloride, and the columns were American Polymer Standards Corp. AM 
GPC Gel 10 m.  The molecular weights were determined relative to narrow molecular 
weight (polydispersity index  1.05) poly(styrene) standards from American Polymer 
Standards Corp.  Thermal transition data were collected with a Mettler DSC 822e.  The 
sample size ranged from 6 – 8 mg, and each sample was subjected to two cool-heat-cool 
cycles from 25 to -50 to 60 °C with a rate of 10 °C/min.  NMR spectra were recorded at 
298 K on a Varian Mercury spectrometer (300 MHz).  Chemical shifts are reported in 
parts per million (ppm), using residual solvent as an internal standard.  Mass spectral 
analyses were provided by the Georgia Institute of Technology Mass Spectrometry 
Facility.  Elemental analyses were conducted at Atlantic Microlab, Inc. in Norcross, GA. 
The synthetic procedures described below represent optimized procedures developed in 
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close collaboration with Warren Gerhardt (Ph.D. thesis, Georgia Institute of Technology, 
2007). 
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2.2.2. Synthesis of Functional Monomers 
 
 
 
 2.2.2.1. 3-Benzyloxy-2-hydroxypropionic acid (4).  H-Ser(benzyl)-OH (20.0 g, 
102.5 mmol) was dissolved in aq. TFA (0.7 M, 200 mL) and NaNO2 (10.6 g, 153.7 
mmol) in deionized water (100 mL) was added over a period of three hours using a 
syringe pump at 25 °C.  The reaction mixture was stirred for an additional three hours at 
25 °C.  NaCl (20.0 g) was added to the reaction mixture and the crude product was 
extracted several times with EtOAc.  The combined organic layers were washed with 
brine, dried over MgSO4, the solvent removed under reduced pressure, and dried in vacuo 
yielding a yellow oil.  The product was further purified by flash column chromatography 
(silica gel, eluant: 97:2:1 CH2Cl2:MeOH:AcOH) and the product was dried in vacuo to 
give a waxy pale yellow solid (15.2 g, 76%).  1H NMR (300 MHz, CDCl3) : 7.25-7.35 
(m, 5H), 4.5 (s, 1H), 4.3 (t, J = 3.7, 1H), 3.7-3.8 (m, 2H);  13C NMR (300 MHz, CDCl3) 
: 173.4, 138.8, 128.4, 127.7, 127.6, 73.1, 72.3, 70.8;  IR (thin film) : 3400, 3028, 2918, 
2864, 1716, 1203, 1095, 735, 696 cm-1;  MS (EI) m/z (relative intensity): 196.1 (M+, 29), 
107.1 (32), 91.1 (100);  HRMS (EI) calcd for C10H12O4: 196.07356, found: 196.07363. 
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 2.2.2.2. 6-(Benzyloxycarbonylamino)-2-hydroxyhexanoic acid (5).  A 1 M 
solution of aq. KHSO4/CH3CN was prepared by dissolving KHSO4 (136.0 g, 1 mole) in 
deionized water (700 mL) and adding CH3CN (300 mL).  H-Lys(Z)-OH (10.0 g, 35.7 
mmol) was dissolved in the solution and it was then cooled to 0 °C and an aqueous 
solution (100 mL) of NaNO2 (37.0 g, 535.7 mmol) was added over a period 20 min using 
a syringe pump.  The reaction mixture was kept at 0 °C and stirred for an additional three 
hours.  NaCl (20.0 g) was added to the reaction mixture and the crude product was 
extracted several times with EtOAc.  The combined organic layers were washed with 
water and brine and dried over MgSO4.  The solvent was removed under reduced 
pressure and the residue dried in vacuo to give a waxy yellow solid.  The product was 
further purified by flash column chromatography (silica gel, eluant: 97:2:1 
CH2Cl2:MeOH:AcOH) and the product was dried in vacuo to give a pale yellow solid 
(6.0 g, 60%).  1H NMR (300 MHz, CDCl3)  7.30-7.50 (m, 5H), 5.5 (s, 2H), 4.2 (dd, J = 
4.2, 7.5, 1H), 3.7 (m, 2H), 1.85-1.75 (m, 1H), 1.70-1.60 (m, 1H), 1.55-1.30 (m, 4H);  13C 
NMR (300 MHz, CDCl3) : 178.1, 154.0, 132.1, 128.8, 128.7, 128.5, 69.9, 69.8, 40.3, 
33.7, 26.2, 22.1;  IR (thin film) : 3345, 2948, 2936, 1731, 1690, 1609, 1583, 1544, 1272, 
748, 731 cm-1;  MS (ES+): 282.2 (M+1). 
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 2.2.2.3. 2-Hydroxypentanedioic acid 5-benzyl ester (6).  This compound was 
provided by Warren Gerhardt (as synthesized in Biomacromolecules 2006, 7, 1735-
1742). 
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 2.2.2.4. 3-(Benzyloxy)-2-(2-bromopropanoyloxy)propanoic acid (7).  (S) 2-
Bromopropionyl chloride (6.3 mL, 61.2 mmol) was added to 4 (10.0 g, 51 mmol) and the 
mixture was heated at 70 °C under an argon atmosphere in a three-neck round bottom 
flask equipped with a NaOH trap.  Once the reaction was completed as shown by thin-
layer chromatography (TLC) (approx. six hours), the dark brown oil was placed in a 
Kugelrohr and distilled at 60 °C and 50 mmHg overnight to remove excess 2-
bromopropionic acid.  Crude 7 was further purified by flash column chromatography 
(silica gel, eluant: 98:1.5:0.5 CH2Cl2:MeOH:AcOH).  The solvent was removed in vacuo 
to give a brown oil in 94% yield.  Compound 7 was carried on to the halogen exchange 
step without further purification. 
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 2.2.2.5. 6-Benzyloxycarbonylamino-2-(2-bromopropionyloxy)hexanoic acid 
(8).  (S) 2-Bromopropionic acid (0.242 mL, 2.7 mmol) and 1-hydroxybenzotriazole 
(HOBt) (0.32 g, 2.4 mmol) were dissolved in dry CH2Cl2 (10 mL).  Once homogeneous, 
the solution was cooled to 0 °C and dicyclohexylcarbodiimide (DCC) (0.42 g, 2.0 mmol) 
was added in one portion.  The reaction was stirred in an ice bath for 5 min and then 
stirred for an additional 20 min at 25 °C.  Dicyclohexylurea (DCU) started to precipitate 
out instantly upon DCC addition.  After a 25 min incubation period, a solution of 5 (0.37 
g, 1.3 mmol) in CH2Cl2 (15 mL) was added dropwise over 20 min via an addition funnel.  
The reaction mixture was stirred for twelve hours becoming a dark brown color.  It was 
then filtered through celite to remove DCU.  The solvent was removed under reduced 
pressure and the brown oil redissolved in EtOAc and cooled in a freezer to precipitate out 
the unreacted DCC which was then filtered off through celite, and washed several times 
with water to remove most of the HOBt.  The solvent was removed under reduced 
pressure and the dark brown oil was placed in a Kugelrohr and distilled at 60 °C and 50 
mmHg overnight to remove excess 2-bromopropionic acid.  Crude 8 was further purified 
by flash column chromatography (silica gel, eluant: 98:1.5:0.5 CH2Cl2:MeOH:AcOH).  
The solvent was removed under reduced pressure and the residue dried in vacuo to give a 
dark brown oil (0.51 g, 93%).  Compound 8 was carried on to the halogen exchange step 
without further purification.
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 2.2.2.6. 2-(2-Bromo-propionyloxy)pentanedioic acid 5-benzyl ester (9).  (S) 2-
Bromo-propionic acid (0.24 mL, 2.7 mmol) and 1-hydroxybenzotriazole (HOBt) (0.32 g, 
2.4 mmol) were dissolved in dry CH2Cl2 (10 mL).  The solution was cooled to 0 °C and 
dicyclohexylcarbodiimide (DCC) (0.42 g, 2.0 mmol) was added in one portion.  The 
reaction was stirred in an ice bath for 5 min and then stirred for an additional 20 min at 
25 °C.  Dicyclohexylurea (DCU) started to precipitate out instantly upon DCC addition.  
After a 25 min incubation period, a solution of 6 (0.32 g, 1.3 mmol) in CH2Cl2 (15 mL) 
was added dropwise over 20 min via an addition funnel.  The reaction mixture was stirred 
for twelve hours becoming a light brown color.  It was then filtered through celite to 
remove the DCU.  The solvent was removed under reduced pressure and the brown oil 
redissolved in EtOAc and cooled in a freezer to precipitate out the unreacted DCC, which 
was then filtered off through celite, and then washed several times with water to remove 
most of the HOBt.  The solvent was removed under reduced pressure and the dark brown 
oil was placed in a Kugelrohr and distilled at 60 °C and 50 mmHg overnight to remove 
excess 2-bromopropionic acid.  Crude 9 was further purified by flash column 
chromatography (silica gel, eluant: 98:1.5:0.5 CH2Cl2:MeOH:AcOH).  The solvent was 
removed under reduced pressure and the residue dried in vacuo to give a brown oil (0.46 
g, 91%).  Compound 9 was carried on to the halogen exchange step without further 
purification. 
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 2.2.2.7. General Procedure for the Halide Exchange.  A solution of the -
bromocarboxylic acid (7-9) in dry acetone (100 mL) was heated to reflux with a large 
excess of KI (approx. 10 equivalents) under an argon atmosphere.  After twelve hours 
(quantitative conversion by TLC) the reaction mixture was filtered through celite and the 
solvent was removed under reduced pressure.  The residual dark red oil was redissolved 
in EtOAc and washed several times with a 2 M aq. Na2S2O3 solution.  After the first 
wash, the dark red color changed to a pale yellow.  The organic layer was dried over 
MgSO4, the solvent was removed under reduced pressure, and the residue was dried in 
vacuo.  The -iodocarboxylic acids (10-12) were used without further purification. 
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 2.2.2.8. 3-(Benzyloxymethyl)-6-methyl-1,4-dioxane-2,5-dione (1).  A solution 
of 10 (5.2 g, 13.9 mmol) in dry CH2Cl2 (100 mL) was added slowly over a period of eight 
hours to a refluxing solution of DIEA (4.6 mL, 27.7 mmol) in dry acetone (1 L) via a 
syringe pump.  After the complete addition of 10 the reaction was stirred for an additional 
hour at reflux and the solvent was removed under reduced pressure.  Et2O (100 mL) was 
added to the light brown oil to precipitate out ammonium iodide, which was filtered off 
through celite and the solvent was removed under reduced pressure.  The linear oligomers 
were removed by passage through a short column of premium grade silica gel (3:1 v/v 
hexanes:EtOAc) to give the crude diastereomeric mixture as a pale brown oil (1.5 g, 
43%).  The diastereomers were separated by flash column chromatography (premium 
grade silica gel, eluant: 80:20  hexanes:EtOAc).  The first diastereomer to elute was 
isolated as a pale brown oil (0.53 g, 36% of mixture).  1H NMR (300 MHz, CDCl3) : 
7.2-7.4 (m, 5H), 5.2 (q, J = 7.0 Hz, 1H), 5.0 (dd, J = 2.1, 2.5 Hz, 1H), 4.5 (s, 2H), 4.0 (dd, 
J = 2.0, 10.5 Hz, 1H), 3.9 (dd, J = 2.6, 10.5 Hz, 1H),1.6 (d, J = 7.0 Hz, 3H).  The second 
diastereomer was recrystallized from Et2O to give a white crystalline solid (0.93 g, 64% 
of mixture).  1H NMR (300 MHz, CDCl3) : 7.2-7.1 (m, 5H), 5.07 (t, J = 3.4 Hz, 1H), 5.0 
(q, J = 6.9 Hz, 1H), 4.6 (s, 2H), 4.0 (d, J = 3.5 Hz, 2H), 1.6 (d, J = 6.9 Hz, 3H);  13C 
NMR (300 MHz, CDCl3) : 166.0, 164.1, 136.4, 128.4, 128.1, 127.9, 76.0, 74.0, 73.1, 
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68.6, 17.8;  IR (thin film) : 3032, 1770, 1749, 1250, 1093 cm-1;  MS (EI) m/z (relative 
intensity): 250.1 (M+, 12), 144 (34), 107 (36), 91.1 (100), 65.1 (11);  HRMS (EI) calcd 
for C13H14O5: 250.08384, found: 250.08412;  Elemental analysis: calcd for C13H14O5: C, 
62.39; H, 5.64; O, 31.97; found: C, 62.36; H, 5.75; O, 32.00;  M.P. 85.4-89.8 °C. 
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 2.2.2.9. Benzyl 4-(5-methyl-3,6-dioxo-1,4-dioxan-2-yl)butylcarbamate (2).  A 
solution of 11 (5.8 g, 12.5 mmol) in dry CH2Cl2 (100 mL) was added slowly over a 
period of eight hours to a refluxing solution of DIEA (4.1 mL, 24.9 mmol) in dry acetone 
(1 L) via a syringe pump.  After the complete addition of 11, the reaction was stirred for 
an additional hour at reflux and the solvent was removed under reduced pressure.  Et2O 
(100 mL) was added to the light brown oil to precipitate out ammonium iodide, which 
was filtered off through celite and the solvent was removed under reduced pressure.  The 
crude product was purified by flash column chromatography (premium grade silica gel, 
eluant: 80:20 hexanes:EtOAc) to give a clear oil which was recrystallized from 
EtOAc/hexanes to give a white crystalline solid (3.19 g, 75%).  1H NMR (300 MHz, 
CDCl3) : 7.4-7.2 (m, 6H), 5.1 (s, 2H), 4.98 (q, J = 5 Hz, 1H), 4.89 (dd, J = 4.3, 2.8 Hz, 
1H), 4.8 (br. s, 1H), 3.22 (q, J = 5.7 Hz, 2H), 2.1 (m, 2H), 1.95 (m, 2H), 1.62 (d, J = 6.7 
Hz, 3H), 1.6-1.4 (br. s, 4H);  13C NMR (300 MHz, CDCl3) :  167.2, 166.5, 155.2, 136.4, 
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128.4, 128.0, 127.95, 75.5, 72.3, 66.6, 40.6, 29.55, 29.5, 21.5, 15.9;  IR (thin film) : 
3331, 2943, 2874, 1782, 1749, 1693, 1688, 1537, 1281, 1265, 1227, 696 cm-1; MS 
(FAB+) m/z (relative intensity): 336.1 (M+1, 100), 292.1 (42), 248.1 (12);  HRMS 
(FAB+) calcd for C17H22NO6: 336.1447, found: 336.14352;  Elemental analysis: calcd for 
C17H21NO6: C, 60.89; H, 6.31; N, 4.18; O, 28.63; found: C, 60.87; H, 6.33; N, 4.16, O, 
28.64; M.P. 94.0-98.6 °C. 
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 2.2.2.10 Benzyl 3-(5-methyl-3,6-dioxo-1,4-dioxan-2-yl)propanoate (3).  A 
solution of 12 (5.5 g, 13.2 mmol) in dry CH2Cl2 (100 mL) was added slowly over a 
period of eight hours to a refluxing solution of DIEA (4.3 mL, 26.3 mmol) in dry acetone 
(1 L) via a syringe pump.  After the complete addition of 12, the reaction was stirred for 
an additional hour at reflux and the solvent was removed under reduced pressure.  Et2O 
(100 mL) was added to the light brown oil to precipitate out ammonium iodide, which 
was filtered off through celite and the solvent was removed under reduced pressure.  
Crude 3 was purified by flash column chromatography (silica gel, eluant: 80:20 
hexanes:EtOAc) to give a light brown oil (2.8 g, 73%).  1H NMR (300 MHz, CDCl3) : 
7.34 (m, 5H), 5.12 (s, 2H), 5.09 (t, J = 3.8 Hz, 1H), 4.95 (q, J = 6.7 Hz, 1H), 2.63 (q, 2H), 
2.48 (m, 1H), 2.21 (m, 1H), 1.64 (d, J = 6.6 Hz, 3H);  13C NMR (300 MHz, CDCl3) : 
171.9, 167.0, 166.5, 135.3, 128.31, 128.07, 127.90, 74.0, 72.1, 66.4, 28.3, 25.0, 15.5;  IR 
: (thin film) 3034, 2999, 2947, 1764, 1732, 1246, 1171, 752, 700 cm-1;  HRMS (ESI+) 
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calcd for C15H17O6: 293.106425, found: 293.101965;  Elemental analysis: calcd for 
C15H16O6: C, 61.64; H, 5.52; O, 32.84. found: C, 61.49; H, 5.59; O, 32.92. 
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2.2.3. Preparation of Protected Homopolymers 
 2.2.3.1. SnOct2 Catalyst Stock Solution.  In a nitrogen-filled glove box, SnOct2 
(0.32 g, 0.8 mmol) ) was added to a 10 mL volumetric flask that was then filled to the 
graduation mark with dry, degassed benzene making a 0.8 M solution, this was 
transferred to a Schlenk flask and stored inside the glove box. 
 
 2.2.3.2. General Procedure for Homopolymerizations.  Monomers 1-3 were 
purified and homopolymerized in collaboration with Warren Gerhardt 
(Biomacromolecules 2006, 7, 1735-1742). 
 2.2.3.3. Homopolymer P1.  1H NMR (300 MHz, CDCl3) : 7.2-7.4 (s, 5H), 5.1-
5.5 (m, 2H), 4.4-4.6 (m, 2H), 3.9-4.0 (m, 1H), 3.7-3.9 (m, 1H), 1.4-1.7 (m, 3H);  13C 
NMR (300 MHz, CDCl3) :  169, 166, 164, 138, 129, 128, 73, 72, 69, 68, 67, 32, 17. 
 2.2.3.4. Homopolymer P2.  1H NMR (300 MHz, CDCl3) : 7.2-7.4 (m, 5H), 4.8-
5.4 (m, 4H), 3.4-3.6 (m, 1H), 3.0-3.2 (m, 1H), 1.4-2.1 (m, 9H));  13C NMR (300 MHz, 
CDCl3) :  169, 168, 156, 137, 129, 128, 72, 69, 66, 40, 30, 29, 22, 16. 
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 2.2.3.5. Homopolymer P3.  1H NMR (300 MHz, CDCl3) : 7.1-7.4 (m, 5H), 4.9-
5.3 (m, 4H), 2.1-2.7 (m, 4H), 1.2-1.6 (m, 3H);  13C NMR (300 MHz, CDCl3) : 176, 172, 
169, 168, 136, 135, 129, 128, 75, 72, 69, 67, 66, 31, 29, 27, 26, 16. 
 35
2.2.4. Preparation of Protected PLA Copolymers 
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 2.2.4.1. General Procedure for Copolymerizations.  Monomers 1-3 were 
copolymerized with lactide in collaboration with Warren Gerhardt (Biomacromolecules 
2006, 7, 1735-1742). 
 2.2.4.2. Copolymer CP1.  1H NMR (300 MHz, CDCl3) : 7.2-7.4 (m, 5H), 5.1-
5.4 (m, 7H), 4.4-4.60 (m, 2H), 3.8-4.0 (m, 2H), 1.4-1.7 (m, 18H), ;  13C NMR (300 MHz, 
CDCl3) : 170, 167, 166, 164, 137, 129, 128, 73, 72, 69, 68, 67, 66, 31, 17. 
 2.2.4.3. Copolymer CP2.  1H NMR (300 MHz, CDCl3) : 7.2-7.4 (m, 5H), 4.8-
5.3 (m, 18H), 3.4-3.5 (m, 1H), 3.0-3.2 (m, 2H), 1.1-2.1 (m, 50H);  13C NMR (300 MHz, 
CDCl3) : 170,169, 168, 167, 156, 137, 129, 128, 78, 72, 69, 66, 40, 39, 30, 29, 22, 20, 
16. 
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 2.2.4.4. Copolymer CP3.  1H NMR (300 MHz, CDCl3) : 7.2-7.4 (m, 5H), 4.9-
5.3 (m, 10H), 2.2-2.6 (m, 4H), 1.4-1.8 (m, 22H);  13C NMR (300 MHz, CDCl3) : 176, 
172, 170, 169, 168, 167, 137, 136, 135, 129, 128, 78, 77, 75, 70, 69, 68, 66, 30, 29, 26, 
25, 16. 
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2.2.5. Preparation of Functional Homopolymers and Copolymers 
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 2.2.5.1. General Procedure for Hydrogenolysis Deprotections.  These homo- 
and copolymers were deprotected in collaboration with Warren Gerhardt 
(Biomacromolecules 2006, 7, 1735-1742). 
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 2.2.5.2. General Procedure for Acidolysis Deprotections of Benzyl 
Carbamates.  These homo- and copolymers were deprotected in collaboration with 
Warren Gerhardt (Biomacromolecules 2006, 7, 1735-1742). 
 2.2.5.3. Homopolymer P1a.  1H NMR (300 MHz, d6-acetone) : 5.1-5.4 (m, 2H), 
3.9-4.1 (m, 1H), 3.7-3.9 (m, 1H), 3.0-3.2 (m, 1H), 1.8-2.0 (m, 1H), 1.4-1.8 (m, 3H);  13C 
NMR (300 MHz, d6-acetone) : 169, 166, 164, 75, 73, 69, 68, 67, 62, 32, 23, 16. 
 2.2.5.4. Homopolymer P2a.  1H NMR (300 MHz, d6-acetone) : 4.8-5.3 (m, 2H), 
3.4-3.5 (m, 1H), 3.0-3.3 (m, 1H), 1.8-2.1 (m, 2H), 1.3-1.8 (m, 7H);  13C NMR (300 MHz, 
d6-acetone) : 172, 169, 72, 69, 40, 29, 28, 26, 20, 16. 
 2.2.5.5. Homopolymer P3a.  1H NMR (300 MHz, d6-acetone) : 5.1-5.4 (m, 1H), 
5.0-5.1 (m, 1H), 2.4-2.8 (m, 2H), 2.2-2.4 (m, 2H), 1.3-1.6 (m, 3H);  13C NMR (300 MHz, 
d6-acetone) : 177, 176, 173, 172, 171, 77, 76, 71, 70, 69, 62, 56, 31, 28, 27, 26, 18.  
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 2.2.5.6. Copolymer CP1a.  1H NMR (300 MHz, CDCl3) : 5.1-5.3 (m, 7H), 3.7-
4.0 (m, 2H), 1.3-1.8 (m, 18H);  13C NMR (300 MHz, CDCl3) : 170, 167, 166, 164, 74, 
73, 69, 68, 67, 32, 22, 17, 16. 
 2.2.5.7. Copolymer CP2a.  1H NMR (300 MHz, CDCl3) : 4.9-5.3 (m, 16H), 3.4-
3.5 (m, 1H), 3.0-3.2 (m, 1H), 1.1-2.1 (m, 50H);  13C NMR (300 MHz, CDCl3) : 170, 
169, 75, 69, 68, 41, 40, 31, 23, 17. 
 2.2.5.8. Copolymer CP3a.  1H NMR (300 MHz, CDCl3) : 5.0-5.3 (m, 8H), 2.4-
2.6 (m, 2H), 2.2-2.4 (m, 2H), 1.4-1.7 (22H);  13C NMR (300 MHz, CDCl3) : 180, 174, 
173, 172, 170, 169, 167, 72, 70, 69, 68, 66, 30, 29, 26, 25, 16. 
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2.3. Results and Discussion (Taken from Biomacromolecules 2006, 7, 1735-1742) 
2.3.1. Synthetic Approaches Towards Functional Monomers 
 Important to the design of our synthetic strategy is the preservation of the 
biorenewable character of our functional monomers whereby we make use of 
commercially available side-chain protected L-amino acids (Figure 2.2).  We rationalized 
that readily available amino acids provide a large diversity of terminal functional groups 
in their side-chains and that they are available as single enantiomers.  To demonstrate the 
modular character of our functional PLA synthesis based on amino acids, we present the 
synthesis of three new functional lactide monomers, 1-3, containing protected amines, 
carboxylic acids, and alcohols in their side-chains (Figure 2.2) as well as their 
homopolymerization and copolymerization. 
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Figure 2.2.  Functional lactide monomers investigated. 
 Our synthetic strategy is based on the simple conversion of amino acids to their 
corresponding -hydroxy acids.  These are then coupled with either (S) 2-
bromopropionyl chloride or (S) 2-bromopropionic acid and cyclized to provide the 
monofunctional lactide (Figure 2.3).   
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Figure 2.3.  Synthesis of cyclic monomers 1 and 2 using an acid chloride coupling.  
Conditions:  (i) NaNO2, TFA, H2O, 25 °C, 6 h;  (ii) NaNO2, aq. KHSO4, 0-25 °C, 3 h;  
(iii) 75 °C, 6 h;  (iv) DIEA, Et2O, 0-40 °C, 12 h;  (v) KI, acetone, 65 °C, 12 h;  (vi) DIEA, 
acetone, 75 °C, 10 h. 
 Our synthetic strategy commences with the diazotization of the amino acid to the 
corresponding -hydroxy acid, with full retention of the stereochemistry.45,46  The 
transformation requires sodium nitrite addition to the amino acid in an aqueous acid 
solution.  As reported by others,45  the yields of the diazotization vary widely based on 
the rate of sodium nitrite addition, choice of acid, and the reaction temperature.  The 
yields shown in Figures 2.3 and 2.4 range from 60% for 5 to 72% for 6.  Since 2-
bromopropionyl chloride is only commercially available in the racemic form, we 
synthesized (S) 2-bromopropionyl chloride from L-alanine by diazotization in HBr to 
provide (S) 2-bromopropionic acid, followed by the conversion to the acid chloride with 
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thionyl chloride.47  The conditions for the cyclization of each functionalized -hydroxy 
acid with lactic acid to provide the functional cyclic diester varied depending on the 
lability of each protecting group (Figures 2.3 and 2.4).   
 The robustness of the benzyl ether protecting group made the synthesis of 
monomer 1 the most convenient with limited side-reactions throughout the synthetic 
pathway.  Ester 7 was synthesized by treating -hydroxy-acid 4 with (S) 2-
bromopropionyl chloride.  Racemization of the enolizable acid chloride -proton in these 
acidic conditions was expected, and the diastereomeric mixture subjected to halide 
exchange by a Finkelstein reaction followed by cyclization without separation.  The 
synthesis of 8, with an acid labile urethane linkage, required the use of lower 
temperatures and the addition of N,N-diisopropylethylamine (DIEA) to scavenge the HCl.  
However, these conditions were still sufficiently harsh generating persistent byproducts, 
which were spectroscopically and functionally quite similar to 8, and therefore difficult to 
remove. Because the final step is an intramolecular reaction, these unidentified 
byproducts posed no threat during the cyclization, and the crude monomer precursor was 
subjected to halide exchange and cyclized, but only low yields of product were obtained.  
We therefore chose to develop an alternative synthesis of monomer 2 that was also 
successfully employed for monomer 3. 
 Monomers 2 and 3 were prepared by the condensation of functionalized -
hydroxy acids with (S) 2-bromopropionic acid using dicyclohexylcarbodiimide (DCC) 
and 1-hydroxybenzotriazole (HOBt) to provide 8 and 9. This method circumvented 
racemization at the new stereocenter through: 1) milder conditions and 2) coupling of an 
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acid instead of the more readily enolizable acid chloride.  These couplings were again 
followed by a halogen exchange and then cyclization, as outlined in Figure 2.4. 
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Figure 2.4.  Synthesis of cyclic monomers 2 and 3.  Conditions:  (i) NaNO2, aq. KHSO4, 
0-25 °C, 3 h;  (ii) NaNO2, 1:1 AcOH/H2O (v/v), 0-25 °C, 3 h;  (iii) DCC, HOBt, CH2Cl2, 
25 °C, 12 h;  (iv) KI, acetone, 65 °C, 12 h;  (v) DIEA, acetone, 75 °C, 10 h. 
 
 The main advantage of the coupling step of -hydroxy acids 5 or 6 with (S) 2-
bromopropionic acid is that the yields of the final cyclization are higher due to a clean 
conversion to the cyclic monomer precursors 8 and 9 versus monomer precursors of 7 
and 8 (with persistent byproducts) generated from the acid chloride coupling method of 
Figure 2.3.   
 Cyclizations of the functional monomer precursors were carried out by slowly 
adding uncyclized -iodocarboxylic acids 10-12 to a dilute solution of DIEA in acetone.  
Linear oligomers, the primary side-products of this procedure, were easily removed by 
filtration of a solution of the crude product through a short plug of silica.  The cyclization 
yield of monomer 1 was 43% with an overall yield 30%.  Diastereomers of 1 from the 
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acid chloride method were separated by column chromatography (we found that premium 
grade silica gel led to significantly higher recovery of product compared to standard 
grade, which led to decomposition of the cyclized monomers), followed by fractional 
crystallization from EtOAc/hexanes.  The configuration of the stereocenters of the 
crystalline diastereomer of 1 was shown to be (S,S) as determined by X-ray structural 
analysis (Figure 2.5).  The absolute configuration of cyclic monomer 1 was determined 
knowing that the stereocenter of the -hydroxy acid half of the molecule retains the (S) 
configuration of the protected amino acid precursor under the diazotization conditions. 
 
Figure 2.5.  Crystal structure of monomer 1. 
 As mentioned earlier the DCC/HOBt method eliminated the problem of 
racemization during the preparation of 8 and 9 thereby allowing for the cyclization to 2 
and 3 with a > 95% diastereomeric excess (as shown by 1H-NMR), in yields 
unprecedented for the cyclization step of any cyclic lactide analogue.  These single 
diastereomers were purified by column chromatography on silica gel, 3 was isolated with 
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a 73% yield as an oil, overall yield of 48%.  Monomer 2 was recrystallized and isolated 
with a 75% yield, overall yield of 42%, as a white crystalline solid.  With the 
configuration of the stereocenter of monomer 2 contributed from the protected amino 
acid half known to be (S), the absolute configuration of the stereocenters of 2 was also 
shown to be (S,S) as determined by X-ray structural analysis (Figure 2.6). 
 
Figure 2.6.  One unique structure in the asymmetric unit cell of monomer 2. 
 It is important to note that our new synthetic methodology allows for the retention 
of the stereochemistry throughout the synthesis of the functional lactides.  The properties 
of poly(lactide)s depends strongly on the tacticity of the final polymers.48  Over the past 
decade, a variety of groups have developed metal catalysts that allow for the control of 
the tacticity during the polymerization with the appropriate lactide stereoisomer(s).49,50  
Therefore, while the scope of this study was not to investigate the stereoregular 
polymerization of our monomers using these catalysts, our synthetic methodology allows 
for the generation or separation of diastereomers that can then be employed in a 
stereoregular homo- or co-polymerization using these metal catalysts.  This allows for 
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complete control over polymer tacticity and thereby the properties of the resulting 
material. 
2.3.2. Synthesis of Protected Functional Homopolymers and PLA Copolymers 
 To determine if our functionalized monomers could be polymerized, preliminary 
homo- and co-polymerizations were performed. For this study we restricted our 
investigation to the use of stannous octoate (SnOct2) as the catalyst.  SnOct2 has been 
approved by the FDA as an indirect food additive51-53 and is among the most active and 
widely used catalyst for the polymerization of lactides and related monomers.22   
 All polymerizations were carried out in bulk.  The monomers and catalyst were 
added to the reaction vessels in a nitrogen-filled glove box, along with a solubilizing 
amount of dry benzene (triply distilled).  The reaction vessels were removed from the 
glove box, the solutions frozen, lyophilized and dried overnight.  They were then heated 
to 140 °C under an atmosphere argon starting the polymerization.  Consumption of all 
monomers occurred within 24 hours for the homopolymers (1H NMR).  For the 
copolymers conversion plateaued at eight hours, with stirring ceasing for CP1 and CP2 
after 3-5 hours (Figure 2.7).  Longer polymerization times (48 hours) and lower catalyst 
ratios (0.1%) did not yield higher molecular weight polymers; these same polymerization 
conditions gave poly(DL lactide) with a Mn of 65,000.  Upon cooling, the polymers were 
purified by precipitation from CH2Cl2 into cold methanol (ice-water bath).  Yields were 
based on the mass of each polymer isolated after precipitations.  All polymers were 
characterized by 1H NMR, 13C NMR, GPC, and DSC (homopolymers Table 2.1; 
copolymers Table 2.2). 
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Figure 2.7.  Homo- and co-polymerizations of 1, 2, and 3. 
 
Table 2.1.  Homopolymer Characterization Data.  aGPC in CH2Cl2 with poly(styrene) 
standards;  bidentical for either diastereomer. 
Polymer Mn (10-3)a PDI Tg (°C) Yield (%) 
P1b 21 1.5 18 79 
P2 8 1.4 20 60 
P3 3 1.4 10 29 
 
Table 2.2.  Copolymer Characterization Data.  aGPC in CH2Cl2 with poly(styrene) 
standards;  bpercentage of functional monomer incorporated into the copolymer was 
determined by 1H NMR after precipitation;  cidentical for either diastereomer. 
Polymer Mn (10-3)a PDI Tg (°C) % copolyb Yield (%) 
CP1c 31 2.0 27 27 % 89 
CP2 24 2.1 25 25 % 72 
CP3 5 1.4 5 14 % 48 
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 Proton NMR showed broad signals characteristic of a polymer, and gel-
permeation chromatography (GPC) confirmed the conversion to high molecular weight 
polymers for homopolymer P1 and copolymers CP154 and CP2.  The lower molecular 
weights of all of these monomers versus lactide is not unexpected owing to the steric bulk 
of the side-chains, which is known to decrease the G of the polymerization.55  However, 
the low molecular weight of copolymer CP3 may indicate that the side-chain of 
monomer 3 has other interactions with the catalyst retarding the polymerization of itself 
and the lactide component.  All of these results are also in agreement with prior reports of 
the polymerization of other lactide analogs40  and substituted morpholine-2,5-dione,20  
and the very low molecular weights of all the polymers derived from monomer 3 were 
also observed in analogs that contain similar functionalities.56  Based on the low 
molecular weights of most of these polymers, the near quantitative conversion of all 
monomers as measured by 1H NMR presumably led to low molecular weight oligomers 
owing to low polymerization rates and/or possible trans esterification reactions.39  
However, the incorporation of the functional monomers into their copolymers is in close 
agreement with the stoichiometric ratio of the monomer:lactide reaction mixtures for 
CP1 and CP2.  Differential-scanning calorimetry of each polymer showed glass-
transition temperatures ranging from 5 to 27 °C, which is below the value for 
poly(lactide) itself.  This can be attributed to the presence of the flexible side-chains, 
which act as internal plasticizers.40   
 These preliminary polymerization results clearly show the potential of monomers 
1 and 2 as new functional poly(lactide) analogues.  The unsatisfactory results obtained for 
monomer 3 may be attributed to retardation of the catalyst by coordination of the benzyl 
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glutamate side-chain.  Also, monomer 3 being an oil was harder to purify and dry in 
contrast to the crystalline monomers, the possible presence of scant amounts of 
adventitious water, despite rigorous drying procedures, may act as an undesirable initiator 
limiting molecular weights.  Through the screening of an array of catalyst/initiator we are 
optimistic that higher molecular weights can be obtained for monomers 1 and 2.  
  
2.3.3. Protected Functional Homo- and Copolymer Deprotection 
 Deprotection of homo- and co-polymers P1 and CP1 derived from serine, and 
homo- and co-polymers P3 and CP3 derived from glutamic acid was accomplished by 
hydrogenolysis using Pd(OH)2 as the hydrogenation catalyst revealing the hydroxyl and 
carboxylic acid functional groups respectively (Figure 2.8A).  Clean and quantitative 
removal of all benzyl ether and ester protecting groups from the homo- and co-polymers 
was confirmed by the disappearance of the aromatic and benzylic signals from the 1H 
NMR and 13C NMR spectra.  This process did not result in the degradation of the 
polyester backbone, as shown by the lack of signals between 4.2 - 4.4 ppm associated 
with the -hydroxy proton that would be apparent upon the cleavage of the backbone 
(Figure 2.9), this was also observed in the 1H NMR spectra of all of the copolymers.  
 However, homo- and co-polymers P2 and CP2 were recalcitrant towards 
hydrogenolysis and were deprotected using HBr (33%)/AcOH for two hours (Figure 
2.8B).  
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Figure 2.8.  Deprotection strategies for protected polymers:  (A) Hydrogenolysis of 
benzyl ethers and esters;  (B) Acidolysis of benzyl carbamates. 
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Figure 2.9.  (A)  1H NMR spectra of serine derivatives in d6-acetone:  1) monomer 1;  
2) homopolymer P1;  3) deprotected homopolymer P1a;  (B) 1H NMR spectra of 
glutamic acid derivatives in d6-acetone:  1) monomer 3;  2) homopolymer P3;  3) 
deprotected homopolymer P3a. 
 Clean and quantitative removal of the benzyl carbamate without backbone 
degradation was again confirmed by 1H NMR and 13C NMR, by observing the 
disappearance of the aromatic and benzylic signals and the absence of a signal in the 
region of the -hydroxy proton in the 1H NMR spectrum (Figure 2.10).  Unfortunately, 
the newly revealed functional groups of all but one of the new homopolymers precluded 
their characterization by GPC owing to solubility problems of the deprotected 
homopolymers in CH2Cl2 and the different hydrodynamic volumes of the deprotected 
copolymers.  GPC analysis of the deprotected copolymer CP1a showed a decrease in 
molecular weight of approximately 35% corresponding to full cleavage of the benzyl 
protecting group and no cleavage of the polymer backbone.  Also the GPC trace of 
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poly(DL lactide) with a Mn of 30,000 had the same Mn and peak shape before and after 
being exposed to each of the deprotection conditions.  
 
Figure 2.10.  1H NMR spectra of lysine derivatives in d6-acetone:  1) monomer 2;  2) 
homopolymer P2;  3) deprotected homopolymer CP2a. 
 
2.4. Conclusions  
 In conclusion, we have developed a modular strategy towards the synthesis and 
polymerization of functional lactides from commercially available protected amino acids.  
To demonstrate this new strategy, we have synthesized three new functional lactide 
monomers containing protected amine, alcohol, and carboxylic acid functionalities, we 
then investigated the homopolymerization behavior using the metal catalyst stannous 
octoate and then successfully copolymerized each monomer with lactide.  Removal of the 
protecting groups from every polymer was quantitative with no scission of the backbone 
observed.  Monomers 1 and 2 had the most promising polymerization results, upon 
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deprotection; these new polymers yielded highly functional, biorenewable materials with 
a multitude of potential applications in the medical field.  Optimization of the 
polymerizations for monomers 1 and 2 will be further investigated, specifically looking at 
an array of catalysts/initiators.  Future work will focus on the development of strategies 
for post-polymerization modification and decomposition studies of these new functional 
materials. 
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CHAPTER 3 
MODIFICATION OF FUNCTIONAL PLA WITH BIOLOGICAL 
LIGANDS‡ 
 
3.1. Introduction 
The use of biodegradable polyesters such as poly(lactic acid) (PLA), 
poly(glycolic acid), and polylactones, in biomedical applications has increased 
significantly over the past decade.1-4 These materials are used in various forms (films, 
fibers, foams) for a diverse set of applications ranging from drug delivery to sutures.5-7 
While the ester functional groups in the background contribute to a set of attractive 
physical properties and facilitate biodegradation, the absence of pendant functional 
groups limits the versatility of these materials. The incorporation of reactive sites that are 
amenable to modification with a wide-variety of biologically relevant ligands would 
provide a host of opportunities to control cell adhesion and function.8 For example, a 
combination of synthetic biodegradable polymers with peptide ligands may provide 
hybrid scaffolds for use in tissue engineering with control over scaffold-cell interactions 
as well as targeted drug delivery.9 Specifically, the attachment of peptides with the RGD 
(Arg-Gly-Asp) sequence has been shown to improve the cytocompatibility and cellular 
attachment characteristics of a variety of materials.10-13  
The main strategy employed to incorporate pendant functional groups into PLA 
involves the copolymerization of cyclic lactide monomer with comonomers14 such as 
functional glycolides,15-19 esteramides,20-25 N-carboxyanhydrides,26-29 and lactides.16,30-33 
                                                 
‡ The ELISA and cell adhesion assays in this chapter were performed with the assistance of Timothy A. 
Petrie from the group of Dr. Andrés J. García; Biomacromolecules 2008, in press. 
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While we34 and others35 have reported the successful copolymerization of lactide 
monomers containing protected functional groups followed by deprotection to provide 
PLA copolymers bearing new chemical functionality (alcohols, amines and carboxylic 
acids), these materials have not been subjected to further post-polymerization 
modification.  
Here we demonstrate the ring-opening copolymerization of cyclic lactide and a 
new dibenzyloxy-substituted lactide, followed by debenzylation to afford a hydroxy-
substituted copolyester. Reaction of the functional copolymer with succinic anhydride 
provides a material that presents carboxylic acid functionality to allow standard 
carbodiimide coupling to attach amine-containing biological molecules. We chose this 
route to prepare carboxylic acid bearing copolylactides over the incorporation of a 
protected carboxylic acid containing monomer owing to the ease of monomer synthesis 
and previous difficulties in polymerizing the protected acid containing lactide.34 We 
posited that incorporation of a small amount of functional comonomer (5 mol%) would 
be sufficient to allow for modification with biomolecules without adversely affecting the 
thermal properties of the copolymer. As proof-of-concept, succinylated films of our new 
functional PLA copolymer were treated with an amine-bearing biotin derivative and an 
Enzyme-Linked ImmunoSorbent Assay (ELISA) was used to demonstrate successful 
coupling. Given the wide interest in interactions between synthetic polymeric materials 
and biological matrices we tethered an RGD-containing peptide sequence 
(GGRGDSPGGK) to the copolymer films. A fluorescence assay of succinylated films 
indicated that the amount of tethered RGD can be controlled by treatment with various 
concentrations of peptide. The function of these films was demonstrated by the enhanced 
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adhesion of mammalian cells to RDG-modified PLA copolymers relative to unmodified 
PLA. This study clearly indicates that the functional groups of the polymer are accessible 
and can be used for the attachment of bioactive ligands to control surface-cell 
interactions. Thus, this presents a versatile approach to functionalizing PLA with 
biomolecules and provides the opportunity to mediate cellular adhesion and impart new 
biological functionality leading to tailorable biodegradable, biocompatible materials with 
numerous potential applications. 
 
3.2. Experimental 
3.2.1. General Methods  
 Benzyl-L-serine was purchased from Indofine Chemical Company. L-lactide was 
purchased from Aldrich and recrystallized twice from dry EtOAc. Dry benzene was 
purchased from VWR and stored in a glovebox. Biotin-PEO-LC-amine was obtained 
from Pierce Chemical Company (product # 21347). Newborn calf serum (NCS) was 
obtained from Hyclone Laboratories (product # SH30118.03). Anti-biotin antibody (BN-
34) was obtained from Aldrich (product # A6561). The fluorescent peptide sequence 
GGRGDSPGGK-FITC (the FITC was attached to the lysine residue) was synthesized by 
the Emory University Microchemical Facility.   
IR spectra were recorded on a Bruker Vector 22 spectrometer. Melting points 
were determined using a Mel-Temp II apparatus. Molecular weight data was collected 
using three Waters Styragel columns (5-m beads: HR 1, 100 Å; HR 3, 1,000 Å; HR 4, 
10,000 Å) connected to a Waters 2690 Separations Module with a Waters 2487 
Refractive Index Detector. The eluant was THF (1 mL/min, 303 K) and the molecular 
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weights were determined relative to six narrow polystyrene standards in THF. Thermal 
transitions were determined on a Mettler DSC 822. The sample sizes were approximately 
4 mg and each sample was subjected to thermal cycles from 0 to 200 ˚C at a rate of 10 ˚C 
per minute. NMR spectra were recorded at room temperature using a Varian Mercury 
spectrometer (300 MHz) or a Bruker AMX spectrometer (400 MHz). Mass spectral 
analyses were performed on a VG Instruments 70SE mass spectrometer. The 
fluorescence intensity of the ELISA samples and RGD assays were recorded using a 
Perkin Elmer HTS 7000 Plus Bio Assay Reader. 
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3.2.2. Synthesis of Dibenzyloxy-substituted Monomer 
 
 
 
 3.2.2.1. (S) 3-Benzyloxy-2-hydroxypropionic acid. 36 The hydroxy acid was 
prepared according to the general method reported by Deechongkit et al.34 A solution of 
NaNO2 (10.6 g, 154 mmol) in H2O (100 mL) was added over 3 h to a solution of O-
benzyl-L-serine (20.0 g, 103 mmol) in 0.7 M aqueous solution of trifluoroacetic acid (200 
mL). The mixture was stirred for 3 h, NaCl (20 g) was added, and the mixture was 
extracted with EtOAc (3 x 200 mL). The organic layers were combined and dried over 
MgSO4. The solvent was removed, and the residue was dried under vacuum overnight to 
give (S)-hydroxy acid as a waxy yellow oil (19.52 g, 97%), which was used without 
further purification. 
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 3.2.2.2. (S,S)-3,6-(Benzyloxymethyl)-1,4-dioxane-2,5-dione (2). A mixture of 
(S) 3-benzyloxy-2-hydroxypropionic acid (10 g, 51 mmol) and p-toluenesulfonic acid 
monohydrate (0.2 g, 1.1 mmol) in toluene (1.5 L) was heated at reflux, and water was 
removed by azeotropic distillation using a Dean-Stark apparatus. After 20 d, the mixture 
was cooled and washed with H2O (6 x 500 mL), dried over MgSO4, and the solvent was 
removed. The residue was recrystallized from anhydrous Et2O to give 2 as a white 
crystalline solid (1.78 g, 21%). m.p. 70.2-73.2 ˚C. 1H NMR (300 MHz, CDCl3)  7.25-
7.35 (m, 10H), 5.13 (t, J = 4.1, -CH-, 2H), 4.49 (d, J = 11.8, diast. -OCH2Ph, 2H), 4.44 
(d, J = 11.6, diast. -OCH2Ph, 2H), 3.89 (d, J = 4.1, -CH2-, 4H). 13C NMR (133 MHz, 
CDCl3)  163.4, 136.7, 128.5, 128.1, 128.0, 76.5, 73.7, 69.9. IR (thin film) ν: 3024 
(weak, aromatic C-H), 2920, 1757, 1247, 1101 cm-1. MS (EI) m/z (relative intensity): 
265.1 (M-PhCH2, 28%), 91.1 (tropylium, 100%) HRMS calcd for C20H19O6 (M-1): 
355.11816, found: 355.11705 (Δ = 3.1 ppm). 
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3.2.3. Preparation of Protected Copolymers 
 
 
 3.2.3.1. Copolymerization of Lactide with Dibenzyloxy-substituted Monomer 
2. A solution of twice-recrystallized lactide (3.8 g, 27 mmol), comonomer 2 (0.50 g, 1.4 
mmol) and SnOct2 (34 μL of a 0.8 M stock solution in benzene) in benzene (75 mL) was 
prepared in a dry-box and freeze-dried overnight. The mixture was heated to 140 °C for 
10 h and poured into MeOH (1 L). The precipitate was collected by filtration and dried 
under vacuum overnight to give protected copolymer 3 as a white solid  (3.69 g, 85%). 
1H NMR (300 MHz, CDCl3)  7.20-7.40 (10 H, -C6H5), 5.3-5.5 (2 H, -CH- of benzyloxy-
substituted repeat unit), 5.0-5.3 (-CH- of LA unit), 4.4-4.6 (4 H, -OCH2C6H5), 3.8-4.0 (4 
H, -CH2OCH2C6H5), 1.4-1.8 (-CH3 of LA unit). 13C NMR (133 MHz, CDCl3)  169.6, 
137.4, 128.4, 127.8, 127.7, 73.4, 69.0, 68.4, 16.6. IR (thin film) 3016 (weak, aromatic C-
H), 2991, 1748, 1178, 1080 cm-1. 
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3.2.4. Preparation of Functional Copolymers 
 
 
 
 3.2.4.1. Deprotection of Copolymer 3 to Afford Hydroxyl-substituted 
Polymer 4. Protected copolymer 3 (1.82 g) was dissolved in a 4:1 (v:v) mixture of 
EtOAc and CH2Cl2 and an equal mass of Pd(OH)2 was added. The solution was placed on 
a hydrogenator and charged to 50 PSI of H2 for 48 h. The catalyst was removed by 
filtration and the solvent was removed to give functional copolymer 4 (1.50 g, 82%). 1H 
NMR (300 MHz, CDCl3)  5.0-5.4 (-CH- of functional repeat unit and LA unit), 4.1-4.3 
(-CH2OH of functional repeat unit), 3.9-4.1 (-CH2OH of functional repeat unit), 1.4-1.8 (-
CH3 of LA unit). 13C NMR (133 MHz, CDCl3)  169.6, 69.0, 67.0, 16.6. IR (thin film) 
2993, 2943, 1748, 1179, 1082 cm-1. 
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3.2.5. Functional Copolymer Modification 
 
 
 
3.2.5.1. Modification of Hydroxyl-bearing Copolymer 4 with Succinic 
Anhydride. Functional copolymer 4 (1.50 g) was treated with succinic anhydride (0.517 
g, 5.17 mmol) (5 equiv. of succinic anhydride per mol of hydroxyl side chain) and 
pyridine (0.5 mL, 6 mmol) (6 equiv. per mol of hydroxyl side chain) in CH2Cl2 (90 mL). 
The reaction mixture was stirred for 10 d, the solvent was removed and the polymer was 
precipitated into MeOH (250 mL) to give carboxylic acid-functionalized copolymer 5 
(1.2 g, 80%). 1H NMR (300 MHz, CDCl3)  5.3-5.5 (2 H, -CH- of succinate repeat unit), 
5.0-5.3 (-CH- of LA unit), 4.4-4.8 (4 H, -CH2OCOCH2CH2COOH), 2.6-2.8 (8 H, -
CH2OCOCH2CH2COOH), 1.4-1.8 (-CH3 of LA). 13C NMR (400 MHz, CDCl3) 169.6, 
69.0, 28.7, 16.6. IR (thin film) 2995, 2958, 1753, 1710 (weak, -CO2H), 1182, 1085 cm-1. 
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3.2.6. Film Formation  
 Films were spin-coated at 2200 rpm on glass discs by applying several drops of a 
25 mg/mL solution of copolymer 5 in a 1:1 (v:v) mixture of toluene and CH2Cl2. The 
glass slides containing the films were placed into the wells of a 24-well plastic plate. 
 
3.2.7. Biotin Coupling  
 Biotin stock solution (600 μL of a solution containing 16 mg biotin-PEO-LC-
amine and 0.9 mg EDC in 14 mL of a 0.1 M aqueous N-morpholinoethane sulfonic acid 
buffer solution adjusted to a pH of 5.5 using NaOH) was added to each well and the 
samples were incubated for 2.5 h at room temperature. The biotin solution was removed 
from the wells by aspiration, and the samples were sequentially incubated in phosphate-
buffered saline (PBS) (no Ca/Mg) for 1 h, a 0.1% (w/v) solution of sodium dodecyl 
sulfate (SDS) in PBS (no Ca/Mg) for 5 min, and DI water at 25 °C to remove any 
physically adsorbed biotin. 
 
3.2.8. RGD-FITC Coupling  
 Films were treated with 2 mM EDC and 5 mM NHS in a 0.1 M aqueous 2-(N-
morpho)-ethanesulfonic acid and 0.5 M NaCl solution (pH 5.5) for 30 min at room 
temperature to activate the carboxylic acids to amidation. Surfaces were subsequently 
immersed in a 20 mM solution of 2-mercaptoethanol in deionized water to quench any 
unreacted EDC,37 leaving activate NHS esters on the PLA films. Films were then 
exposed to various concentrations of the fluorescent peptide GGRGDSPGGK-FITC in 
PBS for 30 min at room temperature in the dark. The free amines on this peptide were 
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covalently tethered to the films using the surface NHS esters as leaving groups. The 
peptide solution was removed from the wells by aspiration, and the samples were 
incubated in 20 mM glycine for 10 min to quench any unreacted NHS esters. After 
carefully transferring the slides to a new set of wells, the films were rinsed three times 
with PBS to remove weakly bound, physically adsorbed RGD-FITC, and the discs were 
subsequently incubated in PBS for 30 min to further reduce non-specific peptide 
adsorption. The solution was removed by aspiration, fresh PBS was added, and the 
fluorescence intensity was measured and quantified. 
 
3.2.9. ELISA  
 The glass discs were incubated in the plastic wells (24-well plastic plates obtained 
from Corning, product # 3526) in newborn calf serum (NCS) for 1 h at 37 °C to block the 
surfaces and washed three times with DI water. A solution of anti-biotin (BN-34, Sigma-
Aldrich) or anti-FITC alkaline-phosphatase conjugated antibody (Sigma-Aldrich) (300 
μL of a solution composed of 7 μL EDTA, 33 μL of a 10 % NaN3 solution, 3 μL of a 1% 
heat-denatured bovine serum albumin solution in PBS, 10 mL DI water and 5 μL BN-34) 
was added to each well and the samples were incubated for 1 h at 37 °C.  The glass discs 
were transferred to a new set of wells to minimize the response caused by the adsorption 
of antibody onto the wells. The dishes were washed five times with DI water, incubated 
in NCS for 10 minutes at 25 °C, and rinsed again five times with DI water. A solution of 
methylumbelliferyl phosphate (300 μL of a solution composed of 7.5 mL DI water, 2 mL 
5X diluted diethanolamine, 500 μL 0.l M NaHCO3, and 0.6 mg of methylumbelliferyl 
phosphate) was added to each well and the samples were incubated at 37 °C for 1 h in the 
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dark. A 50 μL aliquot from each well was transferred into the corresponding well of a 
black Dynex 96-well plate, and the fluorescence intensity was recorded. 
 
3.2.10. Cell Adhesion Assay   
 A wash assay was used to measure relative adhesion of cells adhered to peptide-
functionalized and unfunctionalized film surfaces. MDCK cells were labeled with 4 mM 
calcein-AM in a 2mM dextrose-PBS solution for 20 min and resuspended in α-MEM 
media (1% penicillin-streptomyocin). Cells were seeded onto films at a density of  200 
cells/mm2, and allowed to adhere at 37 °C for 1 h. Wells were then subjected to three 
gentle washes with media to detach loosely bound and unbound cells. After a gentle 
aspiration, post-wash fluorescence was quantified using an HTS 7000 Plus plate reader. 
The post-wash fluorescence levels correlate with the number of adhered cells. 
3.2.11. Statistics. 
  Data are reported as mean ± standard error. Results were analyzed by one-way 
ANOVA using SYSTAT 8.0 (SPSS).  If treatment level differences were determined to 
be significant, pair-wise comparisons were performed using a Tukey post-hoc test.  A 
95% confidence level was considered significant. 
 
3.3. Results and Discussion 
3.3.1. Synthesis of Protected Functional Monomer  
 We have previously reported that benzyl ether-protected lactide 1 is subject to 
copolymerization and reductive debenzylation to afford hydroxyl-bearing PLA 
copolymers.34 In the current study, we chose to adopt a different strategy whereby we 
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prepared the symmetrically di-substituted lactide monomer 2. This makes use of the 
robustness of the benzyl ether protecting group and provides a protected functional 
monomer in fewer synthetic steps. It also provides straightforward access to a single 
enantiomer of the protected functional monomer. Commercially available O-benzyl-L-
serine was converted to (S)-3-(benzyloxy)-2-hydroxypropanoic acid by diazotization 
(NaNO2, TFA) followed by hydrolysis, Figure 3.1.36 Optimization of the reaction 
conditions and simple extraction of the product from the aqueous reaction mixture into 
ethyl acetate gave near quantitative yields of product with full retention of the 
stereochemistry. 
The cyclocondensation of the (S)-hydroxy acid was catalyzed by p-
toluenesulfonic acid, and water was removed from the reaction mixture using a Dean-
Stark trap (20 d). The condensation reaction also provides linear oligomers and 
conversion to the cyclic dimer was typically limited to ca. 40%, which is comparable to 
conversions previously reported for self-condensation reactions for the preparation of 
analogous substituted glycolides.38 Attempts to separate 2 from the linear oligomers by 
column chromatography on silica gel led to ring-opening. However, recrystallization 
proved effective in affording pure protected functional monomer 2. This resulted in lower 
yields (21%) than those found in the literature for the synthesis of alkyl-substituted 
lactides using the same method.30,33 However, while analogous uncyclized alkyl-
substituted oligomers can be thermally cracked at high temperature in the presence of a 
ZnO (a good transesterification catalyst) and vacuum distilled to give cyclic dimer,30 our 
attempts to transform the benzyloxy-substituted oligomers in this fashion led to 
decomposition arising from the high temperatures necessitated by the low volatility of 2. 
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In relation to the preparation of mono-substituted benzyl ether-protected lactide 1, this 
yield is acceptable as the synthetic method has fewer reaction steps, results in the 
formation of a single diastereomer of monomer 2, and yields a dibenzyloxy-protected 
lactide monomer with two potential functional groups per monomer.  
  
Figure 3.1. Synthesis of protected functional monomer 2. 
 
1H NMR analysis was used to verify the stereochemistry of protected functional 
monomer 2. The methine protons of 2 appear as a triplet at 5.14 ppm (J = 4.1 Hz for 
coupling of the methine hydrogen to the neighboring pair of diastereotopic hydrogen 
atoms) corresponding to a single (S,S) stereoisomer, Figure 3.2a. In a separate 
experiment, when a racemic mixture of 3-(benzyloxy)-2-hydroxypropanoic acid 
(prepared from rac O-benzyl-serine) was cyclodimerized, two overlapping triplets were 
observed in the 1H NMR spectrum, one at 5.14 ppm (J = 4.1 Hz) corresponding to the 
(S,S) and (R,R) enantiomers, and the other at 5.12 ppm (J = 2.8 Hz) corresponding to the 
meso (R,S) compound, Figure 3.2b. An X-ray structure of the benzyl-protected functional 
(S,S) monomer 2 is provided in Figure 3.2c, that shows a pseudo-chair conformation of 
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the 1,4-dioxane-2,5-dione ring with the benzyloxymethyl side chains occupying 
equatorial positions.  
 
3.3.2. Copolymerization, Deprotection, and Modification with Succinic Anhydride  
 A 5:95 mixture of protected monomer 2 and L-lactide monomer, (S,S)-3,6-
dimethyl-1,4-dioxane-2,5-dione), was copolymerized using stannous octoate (SnOct2) as 
the catalyst and residual water as the initiator (Figure 3.3).34 The reaction mixture was 
heated to 140 °C to facilitate the ring-opening of monomer 2 as higher temperatures are 
often required to obtain high conversions in the polymerization of substituted lactides.33,38 
1H NMR analysis of the crude copolymerization mixture showed high conversion of both 
cyclic monomers to linear polyester (~90% by integration of the PLA peaks relative to 
lactide monomer). The reaction mixture was poured into methanol to precipitate the 
polymer, which was filtered and dried under vacuum. 1H NMR spectroscopy of the 
resulting material verified that the copolymer (3) included 5% of protected monomer 2. 
The agreement between the amount of protect comonomer and lactide incorpotated into 
the polymer and present in the original polymerization mixture confirms that comonomer 
2 polymerized with an equally high conversion as the lactide monomer (although the  
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Figure 3.2. 1H NMR analysis and X-ray diffraction of cyclic disubstituted dimers: (a) 1H 
NMR spectrum of the methine protons of (S,S) isomer 2; (b) 1H NMR spectrum of a 
diastereomeric mixture of cyclic dimers obtained from rac-hydroxy acid; and (c) X-
ray crystal structure of 2. 
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Figure 3.3. Copolymer synthesis, deprotection, and modification with succinic 
anhydride. 
small amount of unreacted monomer 2 in the crude reaction mixture could not be 
determined directly due to overlap of the signals with those for polymer). While it is 
expected that the substituted protected lactide comonomer has a lower reactivity than 
lactide itself,39 the effect of this on the ratio of comonomers incorporated would only be 
relevant at low conversions. In the current context, we performed polymerizations to high 
conversion with a resulting copolymer with a composition that matched the ratio of 
monomers in the reaction mixture. Gel permeation chromatography (GPC, using 
polystyrene calibration standards) indicated a number average molecular weight of 1.5 x 
104 g/mol. This value is comparable to molecular weights found in the literature for the 
homopolymerization of alkyl-substituted lactides,33 and the copolymerization of 
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protected functional mono-substituted lactides with lactide monomer.34,35 Though 
molecular weights up to 7.7 x 104 g/mol could be obtained, the molecular weight of this 
particular sample could be attributed to the presence of trace amounts of impurities in the 
monomer or catalyst acting as initiators. 
The benzyl protecting groups of copolymer 3 were removed by hydrogenolysis 
over Pd(OH)2 (50 PSI of H2 in a 4:1 (v:v) mixture of EtOAc and CH2Cl2) to give 
functional copolymer 4 with pendent hydroxyl groups. Complete removal of the 
protecting group was verified by 1H NMR spectroscopy by the disappearance of the peaks 
for the phenyl protons at ~7.3 ppm and the appearance of separate one-proton signals at δ 
4.0 and 4.2 ppm for the diastereotopic protons of the methylene group (Figure 3.4B, 
peaks labeled d). The deprotection of copolymer 3 was also confirmed by the 
disappearance of the aromatic C-H stretching vibration at 3016 cm-1 in the infrared (IR) 
spectrum. While the polymer is soluble in EtOAc alone, repeated attempted reductive 
debenzylation in the absence of added CH2Cl2 failed to go to completion. 
The hydroxymethyl-substituted copolymer 4 was treated with succinic anhydride 
to give the acid functionalized copolymer, 5. The progress of the succinylation reaction 
was monitored by 1H NMR spectroscopy. The protons of the methylene group of the 
hydroxymethyl-substituted copolymer 4 shift downfield to δ 4.6 ppm upon esterification, 
with simultaneous formation of peaks attributed to the succinate monoester at 2.7 ppm 
(Figure 3.4C, peaks d and f respectively). The succinylation was also confirmed by the 
appearance of a weak peak at 1710 cm-1 in the IR spectrum for the C=O stretching 
vibration carboxylic acid group. GPC analysis (Table 3.1) indicated that the amount of 
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polymer degradation of the polyester backbone throughout the deprotection and 
succinylation steps was minimal, as observed by a slight decrease in the  
 
Figure 3.4. 1H NMR spectra of copolymers: A, benzyloxy-substituted copolymer 3; B, 
deprotected hydroxymethyl bearing copolymer 4; C, succinylated copolymer 5. 
 
molecular weight. NMR spectroscopy confirmed the preservation of the polymer 
structure and that the polymers had not broken down into monomeric components. The 
copolymers were also characterized by differential scanning calorimetry (DSC), Table 
3.1. Copolymers 3-5 displayed similar glass transition temperatures, and lower melting 
temperatures than literature values for semicrystalline PLA homopolymers derived from 
the ring-opening polymerization of L-lactide.40 This shows that the low level 
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incorporation of difunctional comonomer (5 mol%) does not significantly affect the glass 
transition or melting point of the PLA copolymer. This is in contrast to our previous 
report where greater amounts (25%) of monofunctional monomer 1 incorporated into the 
polymer backbone resulted in a significant decrease in the Tg.34 Copolymer 3 displays a 
strong cold crystallization on first heating, and copolymer 4 was completely amorphous 
after the first heating and cooling cycle. 
 
 
Table 3.1. GPC and DSC Characterization of Copolymers 3-5. 
Copolymer Mn (kg/mol)
Mw 
(kg/mol) PDI Tg (˚C) Tm (˚C)  ΔHm (J/g)
3 15 33 2.2 56 149 9 
4 14 28 2.0 57 152 49 
5 11 21 1.9 61 152 25 
 
 
 
3.3.3. Biotin Coupling  
 The pendant carboxylic acids of 5 provide the opportunity to use standard 
carbodiimide chemistry for attachment of amines. As proof of concept, we coupled an 
amine-substituted biotin derivative to the copolymer films (Figure 3.5). Films of 
succinylated copolymer 5 were prepared by spin-coating a solution (25 mg/mL) of the 
copolymer in a 1:1 (v:v) mixture of toluene and dichloromethane onto glass discs. The 
discs were then placed into wells in a 24-count polystyrene plate and subjected to 
conditions for amidation. To verify the attachment of biotin, we performed an ELISA 
using an alkaline phosphatase enzyme-conjugated anti-biotin antibody. After extensive 
rinsing to remove weakly adhered antibody, a solution of 4-methylumbelliferyl phosphate 
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was added and the fluorescence resulting from the formation of the methylumbelliferone 
anion was quantified and used as a relative measure of the amount of biotin. Films treated 
with the amine-substituted biotin in the presence of EDC show increased fluorescence 
relative to control samples which had been treated with the biotin-amine in the absence of 
EDC (p < 0.005), or treated with a carboxylic acid substituted biotin (with [p < 0.008]  
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Figure 3.5. Attachment of an amine-substituted biotin derivative to copolymer films. 
 
in the presence of ECD, and [p < 0.003] in the absence of EDC), Figure 3.6. The ELISA 
method is not quantitative - the fluorescence intensity is not linearly related to the density 
of antigen (biotin). This arises, in part, from the relative size of the antibody and antigen, 
whereby the fluorescence intensity will saturate at levels far below 5% biotin 
incorporation. The slightly elevated fluorescence levels of the sample treated with the 
biotin-carboxylic acid and EDC relative to the other control experiments can be attributed 
to coupling to small amounts of hydroxyl side chains still present in the sample of 
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succinylated copolymer 5 (which in this case had failed to react completely with succinic 
anhydride). 
  
 
 
3.3.4. RGD-peptide Coupling and Control of Cell Adhesion  
 We also treated the succinylated polymer films with an RGD-containing peptide 
(GGRGDSPGGK) conjugated to a fluorescein derivative (FITC) to demonstrate control 
over the density of tethered bioactive ligand and its subsequent effect on surface-cell 
interactions. The green fluorescence of the FITC was quantified to determine the effect  
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Figure 3.6. ELISA determination of relative density of amine-substituted biotin on 
succinylated PLA copolymer: Relative fluorescence indicating biotin attachment to films 
of copolymer 5 exposed to biotin-amine and biotin-carboxylic acid derivatives with and 
without EDC [Data collected in conjunction with Timothy A. Petrie, School of 
Biomedical Engineering]. 
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of concentration of the peptide in standard NHS/EDC coupling reactions on the density 
of immobilized peptide. Films coupled with RGD-FITC showed increased levels of 
fluorescence, Figure 3.7. Films exhibited increased fluorescence when treated with higher 
concentrations of RGD-FITC and low fluorescence in the absence of EDC activation 
(data point at 20 μg/mL RGD-FITC).  This clearly demonstrates the ability to control 
tethered surface density of bioactive RGD ligand by varying coating concentration. 
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Figure 3.7. Relative fluorescence of succinylated PLA copolymer films 5 exposed to 
RGD at various concentrations with and without EDC (lower data point at 20 μg/mL) 
[Data collected in conjunction with Timothy A. Petrie, School of Biomedical 
Engineering]. 
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Functionalization of the copolymer films with peptides containing the RGD 
sequence, which is a ubiquitous cell adhesion-promoting sequence, should offer control 
over cell adhesion. To validate this assertion, we subjected both RGD-functionalized and 
unfunctionalized copolymer films to a simple adhesion assay using epithelial MDCK 
cells in serum-free media. Films of polymers were exposed for 1 h to MDCK cells 
labeled with calcein-AM, a membrane-permeable green fluorescent-dye. Gentle washes 
with media were performed to dislodge weakly bound cells and post-wash fluorescence 
was recorded to determine the density of cells adhered to the surface. More cells adhere 
to the RGD-tethered films than the unfunctionalized films (p < 0.008), and adhesion is  
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Figure 3.8. Relative fluorescence indicating cell attachment to films of copolymer 5 
exposed to RGD at various concentrations with and without EDC [Data collected in 
conjunction with Timothy A. Petrie, School of Biomedical Engineering]. 
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dependent on RGD-surface density (p < 0.04), Figure 3.8. Taken together, these data 
demonstrate the ability to functionalize PLA films with bioactive ligands and 
subsequently promote cell adhesion. 
 
3.4. Conclusions 
In conclusion, we have synthesized a new protected functional lactide monomer 
and successfully copolymerized it with lactide to give random copolymers that contain 
protected functional groups along the backbone. The copolymers were deprotected and 
used in the ring-opening of succinic anhydride, showing that the functional groups are 
accessible and amenable further modification. Films of the carboxylic acid functionalized 
copolymer were treated with a biotin-amine derivative and the coupling was verified 
using ELISA, showing that the carboxylic acid-functionalized copolymers can be 
modified with amine-terminated biomolecules. Use of a fluorescently labeled RGD-
containing peptide sequence allowed us to verify control over the amount of peptide 
immobilized onto the succinylated copolymer films. Finally, a cell assay was performed 
which showed enhanced cell adhesion to RGD-containing films. This provides a general 
strategy whereby a variety of biomolecules can be attached to functionalized PLA 
copolymers using standard peptide coupling protocols, thereby leading to novel materials 
with numerous potential biomedical applications. 
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CHAPTER 4 
SYNTHESIS OF PHOTOCROSSLINKABLE PLA SCAFFOLDS‡ 
 
4.1. Introduction 
Biodegradable polyesters such as poly(lactic acid) (PLA), poly(glycolic acid), and 
poly(caprolactone) show great promise as materials for use in biomedical applications 
ranging from drug delivery1-4 to scaffolds for tissue engineering.5-8 PLA has gained 
particular attention due to the availability of feedstock monomers from annually 
renewable resources,9 and its controlled degradation into nontoxic products (lactic acid, 
CO2). 10,11 
Polymer scaffolds for tissue growth should be biocompatible, biodegradable, 
highly porous, and have sufficient mechanical properties including a combination of 
toughness and flexibility.12,13 Although the biodegradation of PLA makes it attractive for 
use in biomedical applications, the ability to control the mechanical strength of the 
polymer is crucial in the development of scaffolds.14,15   Methods for modifying the 
physical properties of PLA include the incorporation of other monomers in random 
copolymers (eg., glycolide,16,17 alkyl-substituted lactides,1,18,19 ε-caprolactone20), 
formation of PLA diblock copolymers (eg., with polystyrene21), blending PLA with other 
polymers (eg., ε-caprolactone22 ), and the addition of plasticizers23 and crosslinking 
agents.24,25 However, not all of these techniques are applicable for the synthesis of porous 
scaffolds with suitable mechanical properties for tissue engineering. 
                                                 
‡ The Micro-CT data found in this chapter was obtained and analyzed by Abigail M. Wojtowicz from the 
group of Dr. Andrés J. García.  
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 In addition to tailoring the mechanical properties of PLA, there are numerous 
approaches to incorporate chemical functionality that will allow for the immobilization of 
peptide sequences to provide control over interactions between the scaffolds and adhered 
cells. These include the copolymerization of protected functional lactides,26-29 
glycolides,30-33 esteramides,34-39 N-carboxyanhydrides,40-43 and lactones44-47 with lactide 
monomer to afford functional copolymers to which peptide sequences are 
attached.34,36,40,42 We have previously reported on the synthesis of PLA copolymers with 
pendant functionalities which were used for the attachment of an RGD-containing 
peptide sequence. In this paper we shift our attention from modifying the cellular 
properties of PLA and instead make use of the functional groups to prepare PLA 
copolymers with pendant photocrosslinkable groups.  
 Incorporating photocrosslinkable groups into the backbone of PLA could provide 
a useful method to alter the properties of the polymer. The fabrication of linear and star-
shaped poly(lactide) copolymers with terminal photocrosslinkable acrylate groups has 
been reported.48-52 However, there are only a few reports involving the covalent 
attachment of photocrosslinkable groups directly onto the backbone of PLA,53 and the 
foaming of such materials for use in biodegradable scaffolding has yet to be thoroughly 
explored. 
Of the many different methods used to make porous polymer foams, thermally 
induced phase separation (TIPS) has emerged as a facile route towards the fabrication 
interconnected macroporous scaffolds.54 The parameters of the TIPS process (solvent, 
concentration, temperature) can be easily varied to control pore size, and the method has 
been applied to the preparation of foams from a variety of different polymers.55 The 
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combination of TIPS and the potential to enhance the mechanical properties of the 
polymer by photocrosslinking could be used to overcome many of the shortcomings of 
polymer foams, and provide a route to highly porous, reinforced scaffolds with the 
mechanical properties suitable for tissue engineering.  
 Here we describe the synthesis of a PLA copolymer bearing photocrosslinkable 
cinnamate side chains. The copolymer was foamed using TIPS to give a highly porous, 
biodegradable scaffold with pore sizes large enough to accomodate cell proliferation. The 
UV-irradiation of films and foams of the copolymers resulted in photocrosslinking of the 
cinnamate groups, leading to an increase in the compressive modulus of the foams, and a 
decrease in the rate of hydrolytic degradation. This presents a novel, facile route towards 
well-defined, porous biodegradable scaffolds with limitless potential for use in a variety 
of biomedical applications. 
 
4.2. Experimental 
4.2.1. General Methods  
 L-lactide was purchased from Aldrich and recrystallized twice from dry EtOAc. 3-
Benzyloxy-2-hydroxypropionic acid56 was prepared as previously reported.26 N, N’-
Dicyclohexylcarbodiimide (DCC) (product # A10973) and cinnamoyl chloride (product 
#A12016) were purchased from Alfa Aesar and used as received. 1-
Hydroxybenzotriazole (HOBt) (product #00581) was purchased from Chem-Impex 
International and used without further purification. Dry benzene was purchased from 
VWR and stored in a glovebox. Stannous octanoate (SnOct2) was purchased from 
Aldrich (product #S3252) and distilled prior to use. 
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IR spectra were recorded on a Bruker Vector 22 spectrometer. Melting points 
were determined using a Mel-Temp II apparatus. Molecular weight data was collected 
using three Waters Styragel columns (5-m beads: HR 1, 100 Å; HR 3, 1,000 Å; HR 4, 
10,000 Å) connected to a Waters 2690 Separations Module with a Waters 2487 
Refractive Index Detector. The eluant was THF (1 mL/min, 303 K) and the molecular 
weights were determined relative to six narrow polystyrene standards in THF. Thermal 
transitions were determined on a Mettler DSC 822. The sample sizes were approximately 
4 mg and each sample was subjected to thermal cycles from 0 to 200 ˚C at a rate of 10 ˚C 
per minute. NMR spectra were recorded at room temperature using a Varian Mercury 
spectrometer (300 MHz) or a Bruker AMX spectrometer (400 MHz). Mass spectral 
analyses were performed on a VG Instruments 70SE mass spectrometer. SEM images 
were obtained from Hitachi S-800. Microcomputed tomography (micro-CT) images were 
obtained by Abigail M. Wojtowicz using a Scanco Medical CT 40 imaging system and 
linear attenuation data was reconstructed to generate 3-dimensional images. Samples 
(~240 μm thick sections) were scanned at 6 micron resolution with an integration time of 
300 ms to quantify pore volume. All cross-linking experiments were performed in a 
Rayonet Photochemical reactor (RPR-100) equipped with a cooling fan. Compressive 
mechanical properties of scaffolds were tested using an Instron 5566 instrument. 
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4.2.2. Synthesis of Dibenzyloxy-substituted Monomer using DCC/HOBt 
 
 
 
 4.2.2.1. (S,S)-3,6-(Benzyloxymethyl)-1,4-dioxane-2,5-dione (1). (S)-Hydroxy 
acid 2 (15 g, 76 mmol) was dissolved in 700 mL dry CH2Cl2 and added dropwise to a 
mixture of dicyclohexylcarbodiimide (20 g, 97 mmol) and 1-hydroxybenzotriazole (13 g, 
97 mmol) over a period of 6 h at 50 ºC. After 2 d the solution was cooled to 0 ºC and the 
dicyclohexylurea precipitate was removed by filtration. The solvent was removed, and 
the resulting oily solid was dissolved in ethyl acetate (200 mL). The mixture was washed 
with H2O (3 x 100 mL), dried over MgSO4, and the solvent was removed. The residue 
was recrystallized from anhydrous Et2O to give 1 as a white crystalline solid (4.03 g, 
28%). The spectra of the product matched published data.29 
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4.2.3. Copolymerization of 1 and Lactide, and Deprotection of Copolymer 3 
 
 
 The synthesis and deprotection of protected copolymer 3 was performed as 
previously reported29 with some minor modifications. Lactide monomer, monomer 1, and 
SnOct2 were added to an oven- dried reaction vessel inside a glove box. The vessel was 
removed from the glove box and heated to 120 °C for 16 h. The mixture was dissolved in 
chloroform (100 mL) and poured into cold MeOH (1 L). The precipitate was collected by 
filtration and dried under vacuum overnight to give protected copolymer 3 as a white 
solid. The spectra of the protected copolymer 3 matched published data.29  
Protected copolymer 3 was dissolved in a 4:1 (v:v) mixture of EtOAc and CH2Cl2 
and an equal mass of Pd(OH)2 was added. The solution was placed on a hydrogenator and 
charged to 50 PSI of H2 for 3 d. The catalyst was removed by filtration and the solvent 
was removed under reduced pressure. The resulting solid was dissolved in 
dichloromethane (100 mL), precipitated into methanol (1L), and dried under vacuum to 
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give functional copolymer 4. The spectra of functional copolymer 4 matched published 
data.29 
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4.2.4. Preparation of Cinnamate-modified PLA Copolymers 
 
 
 
 4.2.4.1. Modification of Hydroxyl-bearing Copolymer with Cinnamoyl 
Chloride. Functional copolymer 4 (4.0 g) was treated with cinnamoyl chloride (4.6 g, 27 
mmol) (10 equiv. of cinnamoyl chloride per mol of hydroxyl side chain) and pyridine 
(2.2 mL, 27 mmol) (10 equiv. per mol of hydroxyl side chain) in CH2Cl2 (200 mL). The 
reaction mixture was stirred for 3 d at 45 ºC, the solvent was removed and the polymer 
was precipitated twice into MeOH (1 mL) to give cinnamate-modified copolymer 5 (4.1 
g, 93%). 1H NMR (300 MHz, CDCl3)  7.6-7.8 (2 H, -CH- of alkene of cinnamate repeat 
unit), 7.4-7.6 (4 H, -CH- of phenyl ring of cinnamate repeat unit), 7.2-7.4 (6 H, -CH- of 
phenyl ring of cinnamate repeat unit), 6.3-6.5 (2 H, -CH- of alkene of cinnamate repeat 
unit), 5.4-5.6 (-CH- of backbone of cinnamate repeat unit), 5.0-5.3 (-CH- of backbone of 
LA unit), 4.5-4.8 (-CH2- of cinnamate repeat unit), 1.4-1.8 (-CH3 of LA). 13C NMR (100 
MHz, CDCl3) 169.4 (carbonyl of LA unit), 165.9 (carbonyl of cinnamate ester side 
chain), 145.8 (alkene of cinnamate), 134.0, 130.3, 128.7, 128.0 (phenyl ring of cinnamate 
repeat unit), 116.8 (alkene of cinnamate), 69.6, 68.8 (-CH- of backbone of LA unit), 62.0, 
16.5. IR (thin film) 2993, 2962, 1751, 1722, 1637, 1180, 1080 cm-1. 
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4.2.5. Foam Formation  
 Foams of cinnamate-modified PLA copolymer 5 were prepared using the 
thermally-induced phase separation (TIPS) technique. Either 0.6 mL (to make thinner 
foams) or 1.0 mL (to make thicker foams for compression studies) of a 40 mg/mL 
solution of copolymer 5 in benzene was placed in a half dram vial. The vials were then 
placed in a freezer at -5 ºC overnight. The vials were removed from the freezer and 
placed in liquid nitrogen for approximately 30 s. The vials were removed from the liquid 
nitrogen, and vacuum was applied for 24 h during which the sample remained solid as the 
solvent was removed by sublimation. The resulting foams were removed from the vials, 
and the tops of the foams were cut off (to eliminate the U-shaped feature caused my the 
meniscus of the frozen solution) to give disc-shaped foams of copolymer 5 with a height 
of ~3 mm and a diameter of ~ 8 mm (from the 0.6 mL polymer solutions) or a height of 
~6 mm and a diameter of ~8 mm (from the 1 mL solutions). 
 
4.2.6. Compression Strength Tests  
 The compressive properties of foams of copolymer 5 were tested using an Instron 
5566 operated at a cross-head speed of 1 mm/min using a 10-N load cell. Six specimens 
were measured for each type of sample and the average compression modulus along with 
the standard deviation were calculated. 
4.2.7. Hydrolytic Degradation  
 Foams of copolymer 5 were weighed (~30 mg), immersed in separate vials 
containing PBS and heated to 60 ºC with gentle stirring.  Three different crosslinked and 
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non-crosslinked foams were removed at nine week intervals. The foams were soaked in 
DI water, dried to a constant weight and the average percent mass recovery was recorded. 
 
4.3. Results and Discussion 
4.3.1. Synthesis of Protected Functional Monomer  
 We have established facile methods towards the preparation of polylactide 
copolymers bearing functional groups by the copolymerization of lactide with monomers 
substituted with protected functional groups. We have previously reported the 
copolymerization of mono- and disubstituted and deprotection to afford PLA copolymers 
with pendant alcohol, amine and carboxylic acid functional groups.26,29 We investigated 
the synthesis of dibenzyloxy-substituted lactide monomer 1 by the cyclodimerization of 
(S)-3-benzyloxy-2-hydroxypropanoic acid 2 using a variety of conditions for 
esterification, Figure 4.1. The acid-catalyzed condensation of the (S)-hydroxy acid using 
p-toluenesulfonic acid (TSA) results in the formation of cyclic dimer and linear 
oligomers. Though monomer 1 was easily isolated from the oligomers by 
recrystallization, this procedure resulted in low conversions of the hydroxyl acid (~40%) 
and resulted in low yields (18%) of product.  
Using an alternate method, (S)-3-Benzyloxy-2-hydroxypropanoic acid 2 can be 
cyclodimerized using dicyclohexylcarbodiimide (DCC) and 1-hydroxybenzotriazole 
(HOBt), Figure 4.1. In this approach, we are using carbodiimide chemistry to obtain 
complete ring closure. The resulting yields (28%) were much higher than those obtained 
using the acid-catalyzed condensation reaction (18%) performed on the same scale (15 g 
hydroxyl acid 2). This could be attributed to lower reaction temperature (50 °C) which 
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led to the formation of a smaller amount of linear oligomers as determined by 1H NMR 
spectroscopy. The DCC/HOBt reaction also had the added advantage of a shorter reaction 
time (2 d as opposed to 20 d) and a higher conversion (~80%). Both methods resulted in 
the formation of a single diastereomer of the dibenzyloxy-substituted lactide, which was 
confirmed using 1H NMR spectroscopy and X-ray structural analysis. 
 
Figure 4.1. Synthesis of dibenzyloxy-substituted lactide 1. 
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Figure 4.2. Copolymerization, deprotection and modification with cinnamoyl chloride. 
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4.3.2. Copolymerization, Deprotection, and Modification with Cinnamoyl Chloride 
 Dibenzyloxy-substituted lactide 1 was copolymerized with L-lactide monomer 
[(S,S)-3,6-dimethyl-1,4-dioxane-2,5-dione] in a 5:95 mol ratio with catalytic stannous 
octanoate at 120 ºC in the absence of solvent, Figure 4.2. A small sample was taken from 
the copolymerization mixture and the product was analyzed by 1H NMR spectroscopy. 
Integration of the methine protons of the lactide monomer (5.0-5.3 ppm) relative to the 
methine protons of the polymer (5.3-5.5 ppm) indicated a high conversion (89 %). The 
mixture was poured into a large volume of methanol to precipitate the copolymer and 
separate any unreacted monomer. 1H NMR analysis of the resulting copolymer showed 
the complete removal of the monomer starting material, and integration of the benzylic 
(4.4-4.6 ppm, protons j, Figure 4.3A) and methylene side chain protons (3.8-4.0 ppm, 
protons h, Figure 4.3A) of the copolymer confirmed that 5% protected functional 
monomer 1 had been incorporated into copolymer 3. Gel permeation chromatography 
(GPC, using polystyrene calibration standards) verified the formation of polymers with a 
narrow polydispersity (PDI = 1.2) and a molecular weight of 2.4 x 104 g/mol. 
  The benzyl protecting groups of copolymer 3 were removed by hydrogenolysis 
over Pd(OH)2 (50 PSI of H2 in a 3:1 (v:v) mixture of EtOAc and CH2Cl2). Complete 
removal of the protecting groups was confirmed using 1H NMR spectroscopy by the 
disappearance of the peaks at 7.3 ppm (phenyl protons b-d) and 4.6 ppm (-OCH2-, 
protons j). Debenzylation also resulted in a downfield shift of the diastereotopic 
methylene protons of the side chain, with separation of the 2H peak at ~3.9 ppm for the 
benzyoxy methylene group (Fig 4.3A, signal h) into two separate one-proton peaks at 4.1 
and 4.3 ppm (Fig 4.3B, signal h). Infrared (IR) spectroscopy also confirmed the removal 
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of the protecting groups by the disappearance of the aromatic C-H stretching vibration at 
3016 cm-1. 
 
 
Figure 4.3. 1H NMR spectra of copolymers: A, benzyloxy substituted copolymer; B, 
deprotected hydroxymethyl bearing copolymer; C, cinnamate modified copolymer. 
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side chains (Fig 4.3B, protons h) shifted further downfield to 4.6 and 4.8 ppm (Fig 4.3C) 
upon esterification. Peaks corresponding to the cinnamate ester were observed near 6.5 
and 7.5 ppm (Fig 4.3C, protons a-e). Complete conversion was obtained after 3d as 
observed by 1H NMR spectroscopy. The excess reagents were removed from the reaction 
mixture by precipitation into methanol followed by filtration to give copolymer 4. IR 
spectroscopy indicated the appearance of a characteristic double bond band at 1637 cm-1 
for the C-C and a new shoulder on the peak for the carbonyls of the esters in the 
backbone (1749 cm-1) at 1722 cm-1 arising from the C=O stretching vibration of the 
cinnamate ester side chains.57 GPC analysis confirmed that the polyester backbone 
remained intact during deprotection and modification with cinnamoyl chloride, Table 4.1. 
The random copolymers were also characterized by differential scanning calorimetry 
(DSC), and displayed similar thermal properties to semicrystalline PLA homopolymers58 
and PLA copolymers prepared in our previous report.26 
 
Table 4.1. GPC and DSC Characterization of Copolymers 3-5. 
Copolymer Mn (kg/mol)
Mw 
(kg/mol) PDI Tg (˚C) Tm (˚C)  ΔHm (J/g)
3 24 29 1.2 60 151 19 
4 28 32 1.1 67 159 17 
5 26 30 1.2 69 151 20 
 
 
4.3.3. Photocrosslinking of Cinnamate-substituted PLA Copolymers  
 Incorporation of the cinnamate moieties provides the opportunity to crosslink the 
polymer chains via the photodimerization of the cinnamate side chains by irradiation with 
UV light, Figure 4.4.59 
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Figure 4.4. Photocrosslinking of cinnamate-modified PLA copolymer 5. 
 
 
 Free-standing films of cinnamate-modified PLA were prepared by solvent-casting 
a solution of copolymer 5 in solvent (20 mg/mL) into a glass dish and allowing the 
solvent to slowly evaporate. The resulting film was cut into 2 cm x 2 cm pieces and 
mounted on quartz slides. The films were then irradiated in a Rayonet Photochemical 
reactor (RPR-100) at 300 nm for various times. The progress of the cross-linking reaction 
was monitored using ATR-IR spectroscopy after 0, 1, 2, 4, and 7 h, Figure 4.5. A 
decrease in intensity of the band at 1637 cm-1 for  the C-C double bond was observed as 
the cinnamate side chains undergo photodimerization to the corresponding cyclobutane 
derivative.57 The disappearance of a shoulder at 1722 cm-1, attributed to the C=O 
absorption of the cinnamate ester groups, was also observed. Crosslinking was also 
confirmed by solubility tests. Films irradiated overnight at 300 nm were rendered 
insoluble in dichloromethane, whereas unirradiated films quickly dissolved in the solvent. 
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Figure 4.5. ATR-IR spectra of thick films of cinnamate-modified PLA irradiated for 0, 1, 
2, 4, and 7 h. Spectra were normalized to the C=O stretching vibration of the PLA 
polyester backbone at 1749 cm-1. 
 
 The photocrosslinking of cinnamate-modified PLA was also demonstrated by 
changes in the UV-vis spectra. A thin film of the copolymer was prepared by spin-
coating a solution (10 mg copolymer in 0.8 mL CH2Cl2) directly onto a quartz slide. The 
sample was then irradiated for selected times (0, 0.17, 0.33, 0.50, 1, 2, 3, 4, 6, and 18 h) 
and the progress of the reaction was monitored using UV-vis spectroscopy. Increased 
irradiation time results in a decrease in the  π-π* absorbance of the cinnamate 
chromophore at 275 nm, Figure 4.6.60 
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Figure 4.6. UV-vis spectra showing a decrease in the absorption maxima of the thin films 
of copolymer 5 upon irradiation at 300 nm (0, 0.17, 0.33, 0.50, 1, 2, 3, 4, 6, and 18 h). 
 
4.3.4. Cinnamate-substituted Copolymer Foams  
 Foams were prepared using a modified thermally-induced phase separation 
(TIPS) method, whereby the polymer aggregation and solvent segregation that occurs 
during the freeze-drying of a polymer solution results in the formation of a porous 
polymer matrix.61 A solution of copolymer 5 in benzene (40 mg/mL) was heated to 60 °C 
to aid dissolution. The solution was transferred to vials, which were capped and placed in 
a -5 ºC freezer overnight. The vials were removed from the freezer and exposed to liquid 
nitrogen for 30 s. The caps were removed, and the vials were placed in a dessicator which 
was cooled in an ice bath (this was done to ensure the solutions remained frozen 
throughout the removal of the solvent). The dessicator was subsequently placed under 
vacuum. After 24 h, the vials were taken out of the dessicator and the copolymer foams 
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were removed. Initial attempts to fabricate foams of copolymer 5 by a ternary system 
(15% (w/v) copolymer dissolved in an 87/13 (v/v) dioxane/water) led to ill-defined 
foams. This led us to shift our attention to phase separation involving a simpler binary 
system composed of copolymer 5 and benzene.62 By decreasing the concentration of the 
polymer solution to 4% (w/v) and using benzene as the solvent, well-defined foams of 
copolymer 5 with pore sizes suitable for cellular proliferation (~70 μm) were obtained, as 
demonstrated by microcomputed tomography (micro-CT), Table 4.2. Six smaller-disc 
shaped foams (3 mm height, 8 mm diameter) and three larger foams (6 mm height, 8 mm 
diameter) were analyzed. Micro-CT measurements revealed that the smaller disc-shaped 
foams showed a similar average porosity, pore size, strut thickness, and connectivity 
(within the standard deviation) to the larger foams which were later used in the 
compression strength tests. 
Table 4.2. MicroCT Characterization Data of Foams of Copolymer 5.a 
Sample foam dimensions % porosity pore size strut thickness % connectivity 
 height (mm) diameter (mm)  (μm) (μm)  
1 3 8 88.2 57 17 >99 
2 3 8 84.2 66 19 >99 
3 3 8 88.8 74 18 >99 
4 3 8 89.4 61 16 >99 
5 3 8 84.1 71 20 >99 
6 3 8 86.8 73 20 >99 
  Mean 86.9 ± 2.3 67 ± 7 18 ± 2 >99 
7 6 8 88.6 64 18 >99 
8 6 8 79.9 79 22 >99 
9 6 8 82.2 83 22 >99 
    Mean 83.6 ± 4.5 75 ± 10 21 ± 2 >99 
1' 3 8 86.8 56 16 >99 
2' 3 8 83.3 61 19 >99 
3' 3 8 82.9 71 20 >99 
    Mean 84.3 ± 2.1 63 ± 8 18 ± 2 >99 
a Data recorded by Abigail M. Wojtowicz, Georgia Inst. of Tech., Dept. of Biomed. Eng. 
' After irradiation 
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 The foams of copolymer 5 were also characterized using scanning electron 
microscopy (SEM) (Figure 4.7). It was found that contact between the foams and the 
glass vials during the foaming process resulted in interesting features on the surface of 
foam. For example, SEM images taken of the bottom of the foams (which were in contact 
with the bottom of the glass vials during foaming) resulted in either the formation of 
large tubular pores on the order of 200 μm (Figure 4.7A) or a skin which covered the 
highly porous surface of the foam (Figure 4.7 B). Shearing off the top surface of the foam 
revealed a highly porous interior with pore sizes on the order of ~70 μm (Figure 4.7 C). 
This is consistent with the data (Table 4.2) and cross-sectional images (Figure 4.7D) 
obtained from micro-CT.  
  The porous foams fabricated using TIPS were irradiated in a Rayonet 
Photochemical Reactor (RPR-100) at 300 nm for 16 h. MicroCT analysis of Samples 1-3 
showed negligible changes in the average porosity, pore size, strut thickness, and 
connectivity of the foams upon irradiation (Samples 1'-3', Table 4.2). ATR-IR of the 
crosslinked foams showed complete disappearance of bands arising from the C=O and 
C=C bonds of the pendant cinnamate groups, Figure 4.8. The photocrosslinking of the 
cinnamate-modified PLA foams was also confirmed using solubility tests. The initial 
mass of the irradiated foams were recorded, and the foams were placed in 
dichloromethane for one hour. The foams were removed from the solvent, dried under 
vacuum, and the final mass was recorded. By dividing the final mass by the initial mass 
and multiplying by one hundred, we were able to determine the percent mass recovery.  
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Figure 4.7. SEM images and a micro-CT scan of foams of cinnamate-modified PLA 
copolymer 5 prepared from benzene solutions (4%): A, Image of the bottom surface of 
one of the larger foams (6 mm height, 8 mm diameter); B, Image of the bottom of Sample 
3; C, Image of the top of Sample 4 (after shearing off the meniscus). D, Micro-CT scan of 
a 240 μm thick section of Sample 2 taken at 6 micron resolution [SEM data from Yiqing 
Wang, School of Chemistry and from Amal Raj Puthur Jayapalan, School of Civil and 
1 mm 
A B
C D
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Environmental Engineering; micro-CT data from Abigail M. Wojtowicz, School of 
Biomedical Engineering].    
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Figure 4.8. ATR-IR spectra of nonirradiated (0 h) and irradiated (16 h) foams. 
 
 While nonirradiated foams completely dissolved in the dichloromethane in a 
matter of seconds, the irradiated foams resulted in 80% mass recovery which shows that 
the foams are crosslinked during irradiation. 
 Compression strength tests were performed on the irradiated and unirradiated 
PLA foams to determine the effect of crosslinking on their mechanical properties. 
Cylindrical foams with a height of 6 mm and a diameter of 8 mm were prepared to avoid 
buckling during compression.63  The compressive mechanical properties were measured 
1749 cm-1 
(C=O) 
PLA 
1722 cm-1 
(C=O) 
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1637 cm-1 
(-C=C-) 
cinnamate  0 h 
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using an Instron 5566 instrument. The foams displayed typical stress-strain curves for 
cellular solids with strain-hardening characteristics64 which include a linear elastic 
region, an increasing plateau region where pore collapse occurs, and a densification 
region where the stress rises steeply as the foam is further compressed, Figure 4.9. 
 
Figure 4.9. Typical stress-strain curve of strain-hardening cellular solids. 
 
 
 The compressive modulus was determined from the slope of the initial linear 
regime of the stress-strain curve, Figure 4.10.65 The arrows indicate inflection points as 
the compressed foams make the transition between the linear elastic region and the 
plateau region.  The average compressive modulus of crosslinked foams of cinnamate-
modified PLA copolymer 5 was higher (1.46 ± 0.25 MPa) than foams which were not 
crosslinked (0.84 ± 0.15 MPa). From these results, we can conclude that the 
photocrosslinking of the cinnamate moieties has a significant effect on the compressive 
modulus and overall mechanical properties of the PLA foams.  
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Figure 4.10. Typical stress-strain curves of crosslinked and noncrosslinked foams of 
PLA copolymer 5. 
 
4.3.5. Hydrolytic Degradation of Copolymer Foams  
 An accelerated hydrolytic degradation study was performed using crosslinked and 
noncrosslinked cinnamate-modified PLA foams in order to determine the effect of 
crosslinking on the degradation rate. Copolymer foams (~ 30 mg) were weighed and 
placed in phosphate-buffered saline (PBS) at 60 ºC with gentle stirring. At selected 
intervals, three irradiated and unirradiated foams were removed, soaked in deionized 
water, and dried under vacuum to a constant weight. The mass was recorded and used to 
calculate the average percent mass recovery as a function of degradation time, Figure 
4.11. The data is reported as the mean percent mass recovery of three foams ± the 
standard deviation. Foams of copolymer 5 which were crosslinked showed enhanced 
linear 
elastic 
region 
plateau 
region 
crosslinked 
noncrosslinked
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hydrolytic stability as shown by a high average percent mass recovery (98-99%) after 7, 
9, 18, and 27 weeks. Foams which were not photocrosslinked showed a steady decrease 
in the average percent mass recovery with time, dropping from 92% to 32% as the 
hydrolytic degradation time progressed from 18 to 27 weeks.  
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Figure 4.11. Percent mass recovery of crosslinked (●) and noncrosslinked (▲) foams in 
an accelerated hydrolytic degradation study in PBS at 60 ºC. Curves are to guide the eye. 
 
4.3.6. Dye Penetration in Copolymer Foams 
 Scaffolds used in tissue engineering must be highly porous to facilitate proper cell 
growth15 and the transport of nutrients and metabolic waste.66 In order to verify the 
interconnectivity and porosity of our foams and to explore whether or not the porous 
structures are sufficient for the transport of small molecules, dye penetration studies were 
performed using aqueous FD&C Red #40 dye (disodium 6-hydroxy-5-[(2-methoxy-5-
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methyl-4-sulfophenyl)azo]-2-naphthalene-sulfonate). Foams of cinnamate-modified PLA 
copolymer 5 were prewet by immersion into 100% ethanol, a 50:50 ethanol:PBS solution, 
and a 100% PBS solution with sonication (~1 min) in each solution. The foams were then 
submerged in a solution of Red #40. After 10 minutes, the foams were red, indicating 
penetration of the dye (Figure 4.12 B). Foams cut along the axial position after dye 
exposure showed complete penetration of the dye into the interior of the foam (Figure 
4.12 E).The foams were then placed in a solution of PBS, and the dye was allowed to 
diffuse out of the foams. After 10 min, the foams showed a substantial loss of color 
(Figure 4.12 C), showing that the dye is also able to diffuse out of the foams. Finally, the 
foams were placed in a solution of PBS for 1 min with sonication, which resulted in an 
even greater loss of color (Figure 4.12 D).  
  
     
 
 
Figure 4.12. Cinnamate-modified PLA copolymer foams used in a dye penetration study: 
A, dry foam; B, after pre-wetting in ethanol, 50:50 ethanol:PBS, and PBS (with 
sonication in each solution for 1 min) followed by immersion in a solution of red dye #40 
for 10 min; C, after soaking the dyed foam in PBS for 10 min; D, after soaking the foam 
in PBS for 1 min with sonication; E, Axial cut of the dyed foam showing penetration of 
the dye into the interior of the foam. 
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 Prewetting with ethanol followed by solvent exchange was important to the 
success of this process. Foams which were placed directly in a dye solution overnight 
without prewetting showed a little dye absorption on the exterior, and very little 
penetration into the interior.  
 These results not only confirm the feasibility of using these porous foams as 
scaffolds for cell growth, but also provide a method by which reagents might be infused 
into porous foams of carboxylic acid-functionalized PLA copolymers to facilitate 
modification with peptides (Chap. 3). 
 
4.4. Conclusions 
 In conclusion, we have prepared PLA copolymers with pendant functional groups 
by the copolymerization of lactide with a protected functional monomer. Copolymer 
deprotection and modification with cinnamoyl chloride afforded a PLA copolymer with 
photocrosslinkable side chains. The crosslinking of thin films and of foams was 
demonstrated by IR and UV-vis spectroscopy. Crosslinking of cinnamate-modified PLA 
foams resulted in a 74 % increase in the compression modulus. Crosslinking also led to a 
slower hydrolytic decomposition of the foams. This novel photocrosslinkable, 
biodegradable PLA copolymer shows great promise as a material for use in host of 
biomedical applications ranging from scaffolding for tissue engineering to a 
biodegradable matrix for use in drug delivery. 
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CHAPTER 5 
SYNTHESIS OF PNb-PLA DIBLOCK COPOLYMERS‡ 
 
5.1. Introduction 
 Block copolymers composed of two or more different polymer chains joined 
together to make a single molecule represent a new class of materials with unique 
structural and physical properties.1 Block copolymers have been incorporated into 
everyday applications ranging from packaging tape to asphalt.2 Interactions between the 
different blocks and the  immiscibility of the components can lead to phase separation on 
the nanometer scale into various ordered structures, including cubic packed spheres, 
hexagonal packed cylinders, double gyroid, and lamellar morphologies.3 Though many of 
the current applications of block copolymers do not require the formation of ordered 
morphologies,4 emerging interest in the preparation of ordered nanoporous polymeric 
materials for applications such as nanolithography5 have prompted the investigation of 
block copolymer nanoscale phase separation. 
 Biodegradable implants offer an attractive alternative to other implants since they 
avoid a second invasive surgery for removal.6 However, biodegradable implants often 
lack the required mechanical properties, and are prone to warping and hollowing during 
degradation.7 Methods to improve mechanical strength include the addition of reinforcing 
elements such as polymer fibers,8 and particles such as hydroxyapatite9,10 and 
bioglass.11,12 
                                                 
‡ Hydroxyl-terminated poly(norbornene) was synthesized by Dr. Kunsang Yoon and Dr. Yiqing Wang. 
Characterization (SEC, SAXS, WAXD) provided by Dr. Alexander Norman of NYU. 
 119
Lactide
monomer
P O
O
O
O
P
O
O
O
O
P P F FCopolymerization ofProtected Monomers
with Lactide
Deprotection
OH
P P
PNb-PLA
Diblock Copolymer
Photocrosslinkable
PLA
Protected
PLA
Functional
PLA
PNb-OH
Initiator
P O
O
O
O
or
Reinforced
PNb-PLA Diblock Copolymer Scaffold
Scaffold
Fabrication
UV
Irradiation
Reinforced
PLA Scaffold  
 
Figure 5.1. The fabrication of robust PLA scaffolds by incorporation of 
photocrosslinkable groups or phase-separation of a PNb-bl-PLA diblock copolymer. 
 
 In Chapter 4 we discussed the preparation of PLA copolymers with pendant 
photocrosslinkable groups, Figure 5.1. Irradiation led to crosslinking via the 2 + 2 
cyclodimerization of the cinnamate moieties and resulted in an increase in the 
compressive modulus of polymer foams. This methodology provides a facile route 
towards the preparation of PLA scaffolds with enhanced mechanical properties. Another 
possible route towards the fabrication of mechanically robust foams involves the 
synthesis of a PLA diblock copolymers, where the additional block is composed of a 
rigid polymer which phase separates to form a non-covalent crosslink and thereby 
Chapter 4 
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provides added structural integrity, Figure 5.1.13  In an effort to explore this possibility, 
polynorbornene-block-poly(lactic acid)  (PNb-bl-PLA) diblock copolymers were 
prepared and the thermal and morphological properties of the copolymer were studied. 
PNb was chosen as the rigid block because of its semi-rigid backbone, its ability to phase 
separate,14 ease of synthesis in a controlled fashion,15 and its emerging use in biomedical 
applications.16 The PNb-bl-PLA diblock copolymers were synthesized using a hydroxyl-
terminated polynorbornene as a macroinitiator for the ring opening copolymerization of 
lactide monomer. One PNb-bl-PLA diblock copolymer composition was hydrogenated to 
give h-PNb-bl-PLA in order to explore the effect of the rigid alkene of the PNb block on 
the properties of the copolymer. The rigid polynorbornene blocks have the potential to 
offer mechanical reinforcement by aggregating during the foaming process, and could 
provide a further method for the incorporation of photocrosslinkable groups by 
modification of the norbornene monomer.15 Such materials could have potential for use 
in a variety of applications which extend beyond the strengthening of implant scaffolds to 
the preparation of novel ordered nanoporous materials.  
 
5.2. Experimental 
5.2.1. General Methods  
 L-lactide was obtained from Aldrich and recrystallized twice from dry EtOAc and 
stored in a dry-box. Hydroxyl-terminated PNb15 (Table 5.1)  was prepared by Kunsang 
Yoon and Yiqing Wang from the Weck group as previously reported.17 Dry benzene was 
purchased from VWR and stored in a glovebox. Stannous octanoate (SnOct2) was 
purchased from Aldrich (product # 287172-250G) and distilled prior to use.  
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Table 5.1. Hydroxyl-terminated PNb Characterization Dataa 
Hydroxyl- DP Mn (g/mol) Mn (g/mol) Mw (g/mol) PDI 
terminated PNb (1H NMR) (1H NMR) (GPC) (GPC) (GPC)
PNb180 180 27 400 26 100 37 900 1.45 
PNb122 122 18 500 18 500 33 200 1.79 
PNb129 129 19 600 15 200 23 000 1.51 
aGPCs in THF with poly(styrene) standards 
 The molecular weight data of the hydroxyl-terminated PNb macroinitiators was 
determined by gel permeation chromatography (GPC) using three Waters Styragel 
columns (5-m beads: HR 1, 100 Å; HR 3, 1,000 Å; HR 4, 10,000 Å) connected to a 
Waters 2690 Separations Module with a Waters 2487 Refractive Index Detector. The 
eluant was THF (1 mL/min, 303 K) and the molecular weights were determined relative 
to six narrow polystyrene standards in THF. 
 The molecular weights and polydispersities of the PNb-bl-PLA diblock 
copolymers were determined by size-exclusion chromatography (SEC) using a dual 
column Rheodyne injector equipped with an Agilent UV/Vis detector, a Wyatt DAWN 
Heleos light scattering detector and a WYATT Optiplex ReX refractive index detector. 
Thermal analysis was conducted using a Perkin Elmer 600 DSC. All thermal and 
molecular weight analysis and SAXS and WAXD measurements of the copolymers were 
performed by Dr. Alexander Norman of New York University. SAXS and WAXD 
measurements were carried out on beamline X10A of the National Synchrotron Light 
Source at Brookhaven National Laboratory, Upton, New York.  The storage ring provides 
stored electron beam energy of 2.8 GeV with a maximum operating current of 300 mA, 
which has an approximate lifetime of 20 hours. The wavelength of the incident radiation 
used,  was 1.093 Å (Energy, E = 11 keV), providing a beam flux of greater than 1012 
 122
photons/sec.  The samples were loaded with polyimide (Kapton) windows into a Mettler 
Toledo FP99A hotstage which was mounted vertically between the entrance window and 
the detector. The Bruker CCD camera (has an area of 10.2 x 10.2 cm (1024 pixels x 1024 
pixels)) was placed 14.5 cm from the sample (for WAXD measurements) and 2.05 m 
from the sample (for SAXS measurements).  For SAXS measurements, a flight-tube was 
placed in between the sample holder and the detector.  This flight tube was flushed with a 
steady flow of Argon, minimizing air scatter.  The motors, CCD camera and Mettler 
hotstage were controlled from outside the hutch with a DSP-6002 crate controller running 
SPEC data acquisition software on a UNIX system. 
 The degree of crystallinity and crystallographic form were first investigated by 
WAXD for all samples.  The samples were heated from room temperature to 260 C at a 
controlled rate of 5 C/min and cooled back to 30 C at the same rate. The 2D WAXD 
patterns were collected for 30 seconds and then corrected for the dark image and 
unwarped using the Bruker software SMART.  Pixel number was converted to a 2 scale 
by collecting the WAXD pattern of a known standard: high-density poly(ethylene) 
(HDPE) where the positions of the (110) and (200) reflections are known.  The images of 
every dataset were converted to the BSL file format using XCONV (part of the software 
suite FiberFix for Windows).  A background subtraction was applied to all datasets and 
the 2D data were collapsed to a I(2) vs. 2  plot by performing both equatorial and 
meridional integrations (horizontal and vertical “slices”).   
 The microphase separation was then investigated by SAXS.  The same heating 
and cooling rates were applied as those for WAXD.  The data were reduced and collapsed 
in exactly the same way.  The 1D data were plotted as I(q) vs. q, where q is the scattering 
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vector and is related to the scattering angle by  sin4q .  Silver Behenate was used 
as the SAXS calibrant to convert pixel number to q. The extent of microphase separation 
was determined from the relative peak intensities and the domain spacing between the 
phase separated regions, d is given by: qd
2 . 
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5.2.2. Synthesis of PNb-bl-PLA Diblock Copolymers 
 
   
 5.2.2.1 Copolymerization of Lactide using Hydroxyl-terminated PNb 
Macroinitiator. In a typical polymerization, hydroxyl-terminated PNb (0.50 g, for 
PNb180 Mn= 26,100 g/mol, Mw = 37,900 g/mol, PDI = 1.45, 0.018 mmol hydroxyl chain 
ends),  twice-recrystallized lactide (0.47 g, 3.3 mmol) (an equimolar amount of lactide 
monomer to PNb repeat unit), and SnOct2 (23 μL of a 0.8 M stock solution in benzene; 1 
mol SnOct2 per mol of hydroxyl-initiator) in benzene was prepared in a dry-box. The 
mixture was removed from the glove-box, heated to 60 °C for 2 d, and poured into 
MeOH (400 mL) cooled in an acetone/dry ice bath. The precipitate was collected by 
filtration and dried under vacuum overnight to give PNb-bl-PLA diblock copolymer as a 
white solid (0.95 g, 98%). 1H NMR (300 MHz, CDCl3)  5.3-5.5 (alkene -CH- of PNb 
repeat unit), 5.1-5.3 (-CH- of PLA repeat unit), 3.5-3.7 (-COOCH3 of PNb unit), 2.3-3.3 
(vinylic -CH- and -CHCOOCH3 of PNb unit ), 1.0-2.2 (-CH2- of PNb unit), 1.5-1.7 (-
CH3- of PLA unit). 13C NMR (133 MHz, CDCl3)  176.3, 174.9 (C=O of PNb), 169.5 
(C=O of PLA), 134.4, 133.5, 132.5, 130.9 (alkene C-H of PNb)  68.9 (-CH of PLA), 
51.4, 49.4 (COOCH3 of PNb) 48.2, 47.3, 45.2, 42.4, 41.5 40.6, 36.0 (other -CH and -
CH2- of PNb), 16.6 (-CH3 PLA). 
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5.2.3. Preparation of h-PNb-bl-PLA 
 
 
 
 5.2.3.1. Hydrogenation of PNb-bl-PLA. PNb-bl-PLA (1.00 g) was dissolved in a 
4:1 (v:v) mixture of EtOAc and CH2Cl2 and an equal mass of Pd(OH)2 relative to the 
mass of the PNb block (~0.60 g) was added. The solution was placed on a hydrogenator 
and charged to 50 PSI of H2 for 3 d. The catalyst was removed by filtration and the 
solvent was removed. The polymer was dissolved in CH2Cl2 (15 mL) and precipitated 
into ice cold MeOH (500 mL) to give give h-PNb-bl-PLA (0.65 g, 65%). 1H NMR (300 
MHz, CDCl3) 5.1-5.3 (-CH- of PLA repeat unit), 3.5-3.7 (-COOCH3 of PNb unit), 2.2-
2.9 (-CHCOOCH3 of PNb unit), 1.0-2.2 (other -CH- and -CH2- of PNb). 13C NMR (133 
MHz, CDCl3) (C=O of PNb), 169.4 (C=O of PLA), 68.8 (-CH of PLA), 
51.4, 49.1 (COOCH3 of PNb), 46.7, 44.4, 40.2, 39.0, 36.2, 36.0, 34.7, 34.4 (other -CH 
and -CH2- of PNb), 16.5 (-CH3 PLA). 
 
5.3. Results and Discussion 
5.3.1 PNb-bl-PLA Diblock Copolymer Synthesis and Hydrogenation 
 PNb-bl-PLA diblock copolymers were prepared by the ring-opening 
polymerization of lactide using a hydroxyl-terminated PNb macroinitiator and stannous 
octoate (SnOct2) as the catalyst, Figure 5.2. An equimolar amount of lactide monomer to 
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PNb repeat unit was added, and the solution polymerization in benzene was generally 
allowed to proceed for 2 d. The diblock copolymers were separated from the unreacted 
monomer by precipitation into methanol. The absence of monomer was demonstrated by 
1H NMR spectroscopy, which showed the disappearance of peaks at ~5.0 ppm and ~1.7 
ppm corresponding to the lactide monomer. The polymerization of lactide was confirmed 
by the appearance of two additional peaks at 5.1 and 1.6 ppm (Figure 5.3B, peaks f and g) 
from the PLA. The copolymer structure was also verified by 13C NMR spectroscopy by 
the appearance of peaks at 169.5, 68.9, and 16.6 ppm from the PLA block. By varying the 
chain length of the PNb macroinitiator and the reaction time, several diblock copolymer 
compositions were obtained, Table 5.2. 
 
 
Figure 5.2. Synthesis of PNb-bl-PLA Diblock Copolymers. 
 
 The PNb backbone of one particular sample was hydrogenated over Pd(OH)2 (50 
PSI of H2 in a 4:1 (v:v) mixture of EtOAc and CH2Cl2) to give a hydrogenated PNb-bl-
PLA copolymer, h-PNb-bl-PLA Figure 5.4. Complete conversion was shown by the 
disappearance of the peak corresponding to the vinylic protons in the 1H NMR spectrum 
of the PNb block (Figure 5.3B, protons a) and appearance of a new signal for the protons 
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Figure 5.3. 1H NMR spectra of macroinitiator and copolymers: A, hydroxyl-terminated 
PNb; B, PNb-bl-PLA diblock copolymer; C, Hydrogenated PNb-bl-PLA. 
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of the ethylene (-CH2CH2-) units (Figure 5.3C, protons a’). An upfield shift of protons d 
was also observed upon hydrogenation. The hydrogenation of the PNb block was also 
shown by 13C NMR spectroscopy which showed the complete disappearance of the 
alkene carbons near 134 ppm. 
 
 
Figure 5.4. Hydrogenolysis of PNb-bl-PLA. 
 
Table 5.2. Copolymer Characterization Dataa,b 
Block Mn (g/mol) 
Mn 
(g/mol) 
Mw 
(g/mol) PDI Mn (g/mol) Mw (g/mol) PDI 
Copolymer (1H NMR) (SEC) (SEC) (SEC) (after DSC) (after DSC) (after DSC) 
PNb180-PLA23 30 800 37 000 41 700 1.13 32 400 41 800 1.29 
50 mol% PNb180-PLA45 
+ 50 mol% PLA45 
34 000 23 400 45 700 1.95 19 000 41 100 2.16 
75 mol% PNb180-PLA93  
+ 25 mol% PLA93 
41 700 45 800 53 500 1.17 41 300 51 000 1.24 
PNb180-PLA99 41 700 45 800 53 500 1.17 41 000 51 000 1.24 
75 mol% PNb180-PLA157  
 + 25 mol% PLA157 
50 000 58 200 75 000 1.29 38 000 56 400 1.48 
PNb122-PLA99 33 000 44 600 51 400 1.15 39 100 47 300 1.2 
83 mol% PNb129-PLA93  
+ 17 mol% PLA93 
33 000 47 400 72 500 1.52 / / / 
83 mol% h-PNb129-PLA93 
+ 17 mol% PLA93 
33 000 38 600 68 500 1.77 / / / 
a Characterization data from Alexander Norman 
b GPCs in THF with poly(styrene) standards 
  
 The composition of the PNb-PLA diblock copolymers was determined by end 
group analysis by 1H NMR by comparison of the alkene protons adjacent to the phenyl 
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end group of the PNb chain (Figure 5.5B, protons h), the methylene protons adjacent to 
the hydroxyl initiator of the polynorbornene (protons i ’) and the end group of the PLA 
chain (protons j). By dividing the end group protons by those of the repeat unit for the 
PNb and PLA chains, the DP for each block was calculated and used to estimate the 
molecular weight. In most cases, the ratio of protons h : i ’: j showed good agreement (a 
ratio of 2:2:1) within the error associated with the integration of the small end group 
peaks (10 % of the integral value). However, in some samples, there was an excess of the 
PLA end group proton j relative to protons h and i ’ of the PNb. This was attributed to the 
presence of PLA homopolymer in the sample arising from trace amounts of water in the 
reaction acting as initiator. Therefore, based on the assumption that the PLA 
homopolymer has the same DP as the PLA block of the PNb-bl-PLA copolymer, the 
relative amount of PLA homopolymer was calculated (Table 5.3). 
 
Table 5.3. PLA Homopolymer Data 
Block Copolymer mol % homoPLAa 
PNb180-PLA23 0 
PNb180-PLA45 50 
PNb180-PLA93 25 
PNb180-PLA99 0 
PNb180-PLA157 25 
PNb122-PLA99 0 
PNb129-PLA93 17 
h-PNb129-PLA93 17 
a Calculated using 1H NMR spectroscopy 
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Figure 5.5. 1H NMR spectra showing the end groups of: A, hydroxyl-terminated PNb; B, 
PNb-bl-PLA diblock copolymer; C, Hydrogenated PNb-bl-PLA. *Spinning sidebands 
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5.3.2. Thermal Properties of PNb-bl-PLA 
 The Tg, Tc and Tm of the diblocks were determined using DSC, Table 5.4. Very 
little difference was observed in the thermal properties of the compositions: The Tg and 
Tm were similar to those found in the literature for PLA homopolymer (Tg and Tm values 
from various sources: 55, 170 ºC18 ; 57, 169 ºC19). PNb is generally completely 
amorphous and displays a Tg near 35 ºC.20,21 Though no evidence for phase separation 
was observed (such as the observance of two Tg or Tm) we did not rule out the possibility 
due to the similar Tg of PLA and PNb which might be overlapping in the thermogram and 
the amorphous behavior of PNb which would prevent the appearance of a second Tm. 
 Hydrogenolysis of the PNb129-PLA93 sample to give h-PNb129-PLA93 resulted in a 
decrease of the Tg to 45 ºC and a decrease in the Tm to 149 ºC. This value is similar to 
melting temperatures found in the literature for hydrogenated PNb homopolymers (143 
ºC22, 141 ºC21) and is attributed to the formation of a crystalline material upon saturation 
of the PNb backbone.  
 The molecular weight of the copolymer compositions were characterized by SEC 
before and after the first DSC thermal cycle, Table 5.2. This analysis indicates that there 
is very little degradation to the polymer backbone upon heating (Mn and Mw decrease by 
less than 20 %), which is important if we are to study the interplay of temperature and 
morphology of the polymer. 
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Table 5.4. Thermal Analysis of Copolymersa 
Block Copolymer Tg (˚C) Tc (˚C) Tm (˚C) 
PNb180-PLA23 59 Not observed 157 
50 mol% PNb180-PLA45 
+ 50 mol% PLA45 Not observed Not observed 159 
75 mol% PNb180-PLA93 
+ 25 mol% PLA93 58 102 155 
PNb180-PLA99 60 107 150 
75 mol% PNb180-PLA157  
 + 25 mol% PLA157 62 Not observed 162 
PNb122-PLA99 59 112 159 
83 mol% PNb129-PLA93 
+ 17 mol% PLA93 57 109 152 
83 mol% h-PNb129-
PLA93 + 17 mol% PLA93 45 100 149 
a Characterization data from Alexander Norman 
 
5.3.3. Diblock Copolymer Morphology 
 The microphase separation of the PNb129-PLA93 composition was studied using 
small-angle x-ray scattering (SAXS) and wide-angle x-ray diffraction (WAXD) by Dr. 
Alexander Norman of New York University. The SAXS profile (Figure 5.6A) shows a 
peak which becomes more pronounced as the sample is heated (up to about 130 ºC). This 
was attributed to the crystallization of the PLA block upon heating, which was also 
confirmed by the presence a cold crystallization peak in the DSC trace. It is expected that 
this crystallization results in enhanced microphase separation, which is supported by the 
preservation of the domain spacing (Figure 5.6B). As the temperature is further increased 
above the Tm, the intensity of the peak (Figure 5.6A) continues to decrease, but is still 
present even at higher temperatures. Also, a decrease in the domain spacing (d-spacing) 
occurs as the sample melts (Figure 5.6B), but the sample still shows order even at 
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temperatures of 180 ºC. Both of these results serve as evidence for phase separation even 
after the material has melted. 
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Figure 5.6.  SAXS profile: A, Intensity as a function of scattering vector q;  B, Domain 
spacing as a function of temperature [Data from Alexander Norman, Department of 
Chemistry, NYU]. 
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 WAXD further confirmed the crystallization of the sample upon heating by the 
appearance of sharp Bragg peaks which disappear as the sample is heated above the Tm, 
as shown in the powder diffraction patterns (Figure 5.7A) and the 1D meridional 
integration of the WAXD profile (Figure 5.7B). 
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Figure 5.7. WAXD 2D (A) and 1D (B) patterns of PNb129-PLA93 at various temperatures 
[Data from Alexander Norman, Department of Chemistry, NYU]. 
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5.4. Conclusions 
 Novel PNb-bl-PLA Diblock copolymers were synthesized by the ring-opening 
polymerization of lactide monomer using hydroxyl-terminated PNb macroinitiators. The 
thermal properties of the copolymers were studied along with the morphological 
properties of one particular copolymer composition. SAXS and WAXD showed evidence 
for the crystallization and phase separation of the copolymer upon heating. The ability of 
this material to phase separate could ultimately be used in applications ranging from the 
fabrication of PNb-bl-PLA foams with enhanced mechanical properties to the preparation 
of ordered nanoporous monoliths.  
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CHAPTER 6 
SUGGESTIONS FOR FUTURE STUDY 
 
6.1. Functionalized Hydrogenated PNb-bl-PLA Foams for Tissue Engineering 
 In Chapter 3, the attachment of biological ligands to succinic anhydride modified 
PLA copolymer films was explored. In Chapter 4, photocrosslinkable PLA copolymer 
scaffolds were foamed using TIPS to give highly porous polymer structures which 
showed improved mechanical strength upon crosslinking. Future challenges include 
combining what we have learned regarding the biological modification of functional PLA 
films and the strengthening of polymer foams through crosslinking or diblock  
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incorporation to provide polymer scaffolds with superior mechanical and biological 
properties, Figure 6.1. 
 Such materials could be easily fabricated by building on techniques from our 
previous work, Figure 6.2. A protected functional PNb-bl-PLA diblock could easily be 
synthesized by the copolymerization of dibenzyloxy-substitited lactide (Chap. 3) and 
lactide using a hydroxyl-terminated PNb initiator (Chap. 4). Deprotection, followed by 
modification with succinic anhydride could lead to a hydrogenated PNb-bl-PLA diblock 
copolymer with carboxylic acid functional groups located along the backbone of the PLA 
block. This material has the potential to phase separate during foaming for added stability 
and has pendant carboxyl groups which can be modified with peptides to control cellular 
interactions. 
 
Figure 6.2. The synthesis of functional h-PNb-bl-PLA. 
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 Preliminary experiments on the attachment of peptide to porous PLA scaffolds 
could be carried out using the succinic anhydride-modified functional PLA copolymer 
without the PNb block for the sake of simplicity. The copolymer would have to first be 
foamed using TIPS, and the conditions would have to be optimized to provide a material 
with pore sized suitable for cell migration (>50 m). Efforts would then focus on 
developing methods where a peptide/EDC solution could effectively permeate and 
subsequently be removed from the foams prior to exposure to cells. In the same way, 
solutions containing cells would have to be able to penetrate the foams, and at the end of 
the experiment, unattached cells would ultimately have to be removed in order to 
determine the effect of the peptide on cell adhesion. The complexity of such a task 
(where variables such as the pore size, type of peptide, and type of cells used all play a 
role1) compounded by its lack of precedence in the literature may seem futile. However 
the wealth of information acquired through the exploration of such a material warrants 
further investigation. 
 
6.2. Functionalized PLA Copolymers for Drug Delivery 
 Besides the field of tissue engineering, PLA also show promise for use in drug 
delivery applications due to its biocompatible and degradable properties.2 A variety of 
factors can affect the drug release behavior of PLA including the molecular weight, 
crystallinity, and the Tg of the polymer.3 However, even after optimizing the 
aforementioned conditions, drug release from a PLA matrix can be slow.4 Many methods 
focus on increasing rate of drug release through the addition of small molecules.5 Low 
molecular weight esters were added during the preparation of PLA films and resulted in a 
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decrease in the Tg and in increase in the degradation rate.6 Hydroxyesters such as 
diethyltartrate (DET) were added to PLA films which showed enhanced drug release 
relative to unmodified films. Molecular weight analysis of the PLA films with the added 
DET revealed that the increased rate of drug release was not due to increased hydrolysis 
from the hydroxyl functional groups of the DET. Further testing of the DET modified 
films showed that the enhanced degradation was caused by an increase in the amount of 
water uptake and the formation of open pored structure. 
 Another possible approach to modifying the drug release behavior of PLA which 
is not based on the addition of small molecules involves the modification of the side 
chains our functional PLA copolymers. We have already shown that incorporating 
pendant protected functional groups into PLA in high mol percentages (Chap.2) can be 
used to decrease the Tg of the copolymer. This should result in an increase in the 
degradation rate of the copolymer relative to PLA homopolymer.6 Directly attaching 
various hydrophobic or hydrophilic groups to the functional side chains could also be 
used as a means to alter the rate of degradation of PLA. For example, incorporation of 
hydrophobic side chains into the copolymer could lead to phase separation during film 
formation and enhanced loading and release of hydrophobic drugs.5 On the other hand, 
incorporation of a hydrophilic segment, such as a poly(ethylene glycol) oligomer or a 
ring-opened sugar could result in an increase in the water uptake and degradation rate.3 
 We have previously shown (Chap. 4) that the photocrosslinking of PLA scaffolds 
led to a decrease in the rate of hydrolytic degradation. Such effects should carry over to 
polymer films, which could be loaded with drugs and used in the development of long-
term drug delivery materials or hydrogel applications.7 The photocrosslinking of PLA 
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films might also be used to prevent the initial burst of excess drug from the surface that is 
often associated with implants.8 
 The fabrication of the aforementioned materials would require synthetic 
procedures which are mere extensions of work we have previously performed, and 
confirms the necessity for further exploration towards the advancement of these materials 
for use in future biomedical applications.  
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APPENDIX A 
KINETIC STUDIES ON THE RING-OPENING POLYMERIZATION OF 
SUBSTITUTED LACTIDES 
 
A.1. Introduction 
 The copolymerization of substituted lactides with lactide monomer has proved to 
be a facile method to altering the properties of PLA.1 However, issues concerning the 
slower reactivity of monomers with bulky substitutents relative to lactide prompted us to 
initiate an investigation of the relative rates of ring-opening polymerization of substituted 
lactides.2,3 We set out to synthesize an isopropyl-substituted monomer and study the 
effect of the bulky isopropyl substituent on the polymerization kinetics. Our initial goal 
was not necessarily to quantitatively determine the rate constant or relative reactivity 
ratio of the monomer, but instead gain a general understanding of the role of the 
isopropyl-substituent in the coordination-insertion mechanism of the stannous octanoate 
catalyst and the subsequent ring-opening of the monomer.  The polymerization was 
monitored using 1H NMR spectroscopy. Analysis of end groups by 1H NMR as the 
reaction proceeded allowed us to gain some insight to which carbonyl of the cyclic ester 
monomer the catalyst of the propagating chain end preferentially coordinated and 
inserted. Future work involving the synthesis of model compounds which resembled the 
active chain ends present during the polymerization was initially proposed in order to 
support the results obtained from the polymer end group analysis. However, a sudden 
surge of interest in the area4,5 led us to ultimately abandon our study and shift our 
attention from substituted lactides to protected functional lactides (Chp.2). 
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A.2. Experimental 
A.2.1. General Methods  
 2-Hydroxy-3-methylbutyric acid (product # 219835-5G) and 2-bromopropionyl 
bromide (product #249785-100G) were purchased from Aldrich and used as received. N-
ethyldiisopropylamine (product # A11801) was obtained from Alfa Aesar and used 
without further purification. Stannous octanoate (SnOct2) (product # 287172-250G) and 
4-tert-butylbenzyl alcohol (BBA) (product # 184268) were purchased from Aldrich and 
the SnOct2 was distilled prior to use. 1H-NMR spectra were recorded at 298 K on a 
Varian Mercury spectrometer (300 MHz). 
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A.2.2. Synthesis of Isopropyl-substituted Lactide Monomer 
 
 
 
A.2.2.1. 3-Methyl-6-isopropyl-1,4-dioxane-2,5-dione (1). Compound 1 was 
prepared as previously reported in the literature.4 2-Hydroxy-3-methylbutyric acid (10 g, 
85 mmol) and 2-bromopropionyl bromide (10 mL, 95 mmol) were stirred for 3 h at 80 
ºC. The reaction mixture was then dissolved in 200 mL of dry acetone and added 
dropwise to a solution of N-ethyldiisopropylamine (30 mL, 170 mmol) in refluxing 
acetone (100 mL) over a period of 6 hours, after which the reaction was allowed to 
proceed overnight. The ethyldiisopropylammonium salt was removed from the mixture 
by filtration, and the solvent was removed. The mixture was re-dissolved in 
dichloromethane (20 mL), washed with H2O (3  100 mL), dried over MgSO4, and the 
solvent was removed. The resulting oil was recrystallized from Et2O (20 mL) to give a 
racemic mixture of 1 as a white crystalline solid (5.2 g, 36%). The spectra of the product 
matched published data.4 
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A.2.3. Polymerization of Isopropyl-substituted Lactide Monomer 
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 A.2.3.1. Homopolymerization of Monomer 1. Isopropyl-substituted lactide 1 
(0.1978 g, 1.15 mmol) and SnOct2 catalyst (50 μL of a 0.34 M solution in toluene; 1.5 
mol % to monomer) were added to a dry flask and heated to 110 ºC. 4-tert-butylbenzyl 
alcohol (BBA) initiator (50 μL of a 1.52 M solution in toluene; 0.076 mmol; M:I ratio of 
15:1) was added, and the timing of the reaction began. At selected intervals, an aliquot 
was quickly removed, placed in a vial, and dissolved in deuterated chloroform for 1H 
NMR end group analysis. 
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A.3. Results and Discussion 
A.3.1. Isopropyl-substituted Lactide Preparation 
 Monomer 1 was synthesized by the reaction of 2-hydroxy-3-methylbutyric acid 
with 2-bromopropionyl bromide, Figure A.1. The initial reaction of the hydroxyl group of 
the hydroxy acid with the acyl bromide was quick, taking only 3 h for the hydroxy acid to 
be consumed as determined using 1H NMR analysis. In the following step, the 
intermediate was slowly added dropwise to a solution of N-ethyldiisopropyl amine to 
promote the formation of cyclized product rather than linear oligomer. Ring closure 
under basic conditions followed by selective recrystallization afforded a single set of 
enantiomers (S,S and R,R as determined using x-ray crystallography) with reasonable 
yields (36 %) considering the nature of the reaction and the potential formation of linear 
oligomers. 
 
-HBr
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OH
O
OH
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O
O
O
S
S
O
Br
Br
+ OH
O
O
O
Br
iPr2NEt
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reflux, 24 h
O
O
O
O
* * *
*
*
*
(rac.)
1  
Figure A.1. Synthesis of monomer 1. 
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A.3.2. Polymerization of Isopropyl-substituted Lactide 
 The bulk polymerization of monomer 1 was carried out using stannous octanoate 
as the catalyst and t-butyl benzyl alcohol as the initiator. The polymerization was carried 
out at 110 ºC to facilitate the rapid ring-opening of the substituted lactide within a 
reasonable amount of time. At various times, an aliquot was removed from the 
polymerization mixture and dissolved in deuterated chloroform for 1H NMR analysis. 
 
 
Figure A.2. Polymerization of monomer 1 with SnOct2 catalyst and BBA initiator. 
 
The ratio of isopropyl and methyl end groups (i-Preg:Meeg) was monitored as a 
function of time using 1H NMR spectroscopy (Figure A.3) in an attempt to gain insight 
into the relative reactivity of the esters of the alkyl-substituted monomer and the two 
types of chain ends, Figure A.4. The kinetics of the polymerization are described by rate 
constants k1, k2, k3 and k4, Figure A.4. 
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Figure A.3. Representative 1H NMR spectrum used for end group analysis. 
 
 
 
Figure A.4. The four possible chain propagations in the polymerization of 1. 
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 The relative amounts of methyl (Memc) and isopropyl (i-Prmc) repeat units of the 
main chain and the t-butyl end group (t-Bueg) were monitored by 1H NMR spectroscopy. 
This allowed for calculation of the degree of polymerization (DP):  
 
]Bu-[
]Pr-[]Me[
DP     (1)
eg
mcmc
t
i  
 
Alternatively, comparing the rates of the main chain units and the isopropyl and methyl 
substituted alcohol end groups (i-Preg, Meeg) could also be used to calculate the DP: 
 
]Pr-[]Me[
]Pr-[]Me[
DP     (2)
egeg
mcmc
i
i

  
 
The ratio of monomer to initiator (M/I) was calculated by dividing the amount of 
monomer (and reacted polymer) by the amount of t-butyl end group. The M/I ratio was 
multiplied by the percent conversion for calculation of the DP: 
 
conversion %  
[I]
[M]DP     (3)   
 
 For the most part, the percent conversion increased with time (within the ±2 % 
error associated with the 1H NMR integration of the unconsumed monomer and polymer 
main chain peaks), Table A.1. The DP values show good agreement (within ± 2 repeat 
units due to error associated with the integration of the 1H NMR peaks) except for 
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outliers at the beginning and end of the reaction. This indicates that residual water was 
sufficiently removed from the system. Initial experiments which were contaminated with 
trace amounts of water resulted in the formation of additional methyl and isopropyl end 
groups (compared to the t-butyl end groups). This is due to the ability of water to act as 
an initiator in a manner analogous to the t-butyl benzyl alcohol. Since the water produced 
extra methyl and isopropyl end groups, yet the amount of t-butylbenzyl initiator end 
groups remained unchanged, different values for the DP were obtained when using 
equations 1 and 2. The results cast doubt on previous works where the DP was calculated 
using only the t-butyl end group (eq. 2). 
 
Table A.1. Degree of Polymerization and End Group Comparison 
Time 
% 
Conversion 
DPa  
(i-Preg + Meeg) 
DPb  
(t-Bueg) 
DPc 
% Conversion*(M/I) 
[i-Preg] 
[Meeg] 
0.5 h 63 12 6 8 8.5 
1 h 87 8 8 10 6.8 
1.5 h 93 14 11 13 7.1 
2 h 91 14 12 13 6 
2.5 h 95 14 13 14 5.8 
3 h 97 14 13 14 4.6 
3.5 h 96 14 14 16 5.1 
4 h 89 13 9 11 4.8 
a DP calculated from dividing the protons of the main chain repeat units by the isopropyl 
and methyl end groups of the polymer 
b DP calculated from the t-butyl end groups of the polymer 
cDP calculated from the % conversion multiplied by the M/I ratio 
 
 From the four possible chain propagations mechanisms (Figure A.4), k1 and k3 
result in the formation of an isopropyl end group (i-Preg) and k2 and k4 result in the 
formation of a methyl end group (Meeg). By integrating the protons associated with the 
isopropyl and methyl end groups throughout the polymerization (Figure A.3), we can 
draw conclusions regarding the corresponding rate constants: 
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]Me[
]Pr-[
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][
     (4)
eg
eg
42
31 i
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
 
 The ratio of isopropyl: methyl end groups is approximately 8:1 throughout the 
early stages of the reaction (< 90 % conversion) which suggests that the SnOct2 
coordination-insertion catalyst shows preference toward coordinating with the carbonyl 
adjacent to the less sterically hindered methyl group of the monomer (k1, k3) over the 
carbonyl adjacent to the bulky isopropyl group (k2, k4). These results are consistent with 
similar experiments found in the literature involving the polymerization of mono- and di-
substituted lactides, Figure A.5.5 It has been shown that if the methyl groups of lactide 
are replaced by groups with can provide a relatively greater amount of steric hindrance 
(such as isopropyl, cyclohexyl, or phenyl3 groups), this leads to a decrease in the 
reactivity of the monomer during ring-opening polymerization with stannous octanoate.  
 
 
Figure A.5. Demonstration of decreasing reactivity (from left to right) as the bulkiness of 
the substituent increases. 
 
 The decrease of the isopropyl: methyl end group ratio towards the end of the 
reaction (>90%) could be attributed to competing depolymerization reactions involving 
the isopropyl and methyl substituted alcohol end groups. These depolymerization 
reactions, which proceed through a transesterification mechanism rather than the 
coordination-insertion propagation mechanism, perhaps favor the formation of an equal 
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ratio of isopropyl to methyl end groups and therefore result in a decrease in the isopropyl: 
methyl end group ratio as it tends towards a value of 1. 
 The reaction of model compounds which contain functional groups similar to the 
propagating chain ends offers a different approach to determine relative rates to gain 
insight into the kinetics of the polymerization reaction, Figure A.6. In order to explore the 
kinetics of how a propagating chain end adjacent to a methyl group attacks the monomer 
(Figure A.3; k3, k4), an excess of commercially available 3-hydroxy-2-butanone 2 was 
combined with isopropyl-substituted lactide 1 and stannous octoate.  The reaction 
mixture was heated at 110 °C for 10 min. The 1H NMR spectrum showed an isopropyl: 
methyl end group ratio of approximately 2:1 (k3>k4), confirming once again the 
coordination of the catalyst to the less sterically hindered carbonyl. 
 
Figure A.6. Model compounds to explore the kinetics of the ring-opening of 1. 
  
 4-Methyl-3-hydroxy-2-pentanone 3 (Figure A.5) would have bee our choice to 
serve as a model for the isopropyl substituted chain ends (Figure A.3; k1, k2). However, 
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the appearance of new work4 in the literature led us to focus instead on the synthesis of 
protected functional lactides (Chp.2). 
 
A.4. Conclusions 
 An isopropyl-substituted lactide was synthesized and used to study the effect of 
the presence of bulky substituent on the ring-opening of the monomer. 1H NMR end 
group analysis showed that the SnOct2 catalyst preferred coordinating to the less 
sterically-hindered carbonyl, confirming that the presence of the bulky isopropyl groups 
does play a role in the polymerization kinetics.  
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APPENDIX B 
SPECTROSCOPIC CHARACTERIZATION OF SYNTHETIC PRODUCTS 
 
 1H NMR spectra were recorded at room temperature using a Varian Mercury 
spectrometer (300 MHz), and the 13C NMR spectra were obtained at 100 MHz using a 
Bruker AMX spectrometer. IR spectra were recorded on a Bruker Vector 22 
spectrometer. 
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Figure B.1. 1H NMR of 3-Benzyloxy-2-hydroxypropionic acid (4). 
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Figure B.2. 1H NMR of 6-(Benzyloxycarbonylamino)-2-hydroxyhexanoic acid (5). 
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Figure B.3. 1H NMR of 2-Hydroxypentanedioic acid 5-benzyl ester (6). 
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Figure B.4. 1H NMR of 3-(Benzyloxy)-2-(2-bromopropanoyloxy)propanoic acid (7). 
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Figure B.5. 13C NMR of 3-(Benzyloxy)-2-(2-bromopropanoyloxy)propanoic acid (7). 
255075100125150175200
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Figure B.6. 1H NMR of 6-Benzyloxycarbonylamino-2-(2-bromopropionyloxy)hexanoic acid (8). 
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Figure B.7. 13C NMR of 6-Benzyloxycarbonylamino-2-(2-bromopropionyloxy)hexanoic acid (8). 
255075100125150175200
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Figure B.8. 1H NMR of 2-(2-Bromo-propionyloxy)pentanedioic acid 5-benzyl ester (9). 
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Figure B.9. 13C NMR of 2-(2-Bromo-propionyloxy)pentanedioic acid 5-benzyl ester (9). 
255075100125150175200
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Figure B.10. 1H NMR of -iodocarboxylic acid intermediate (10). Spectrum contains residual EtOAc (4.1, 2.0, and 1.3 ppm). 
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Figure B.11. 13C NMR of -iodocarboxylic acid intermediate (10). 
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Figure B.12. 1H NMR of -iodocarboxylic acid intermediate (11). 
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Figure B.13. 1H NMR of -iodocarboxylic acid intermediate (12). 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0
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Figure B.14. 1H NMR of 3-(Benzyloxymethyl)-6-methyl-1,4-dioxane-2,5-dione (1). 
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Figure B.15. 13C NMR of 3-(Benzyloxymethyl)-6-methyl-1,4-dioxane-2,5-dione (1). 
102030405060708090100110120130140150160170180190200
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Figure B.16. 1H NMR of Benzyl 4-(5-methyl-3,6-dioxo-1,4-dioxan-2-yl)butylcarbamate (2). 
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Figure B.17. 13C NMR of Benzyl 4-(5-methyl-3,6-dioxo-1,4-dioxan-2-yl)butylcarbamate (2). 
102030405060708090100110120130140150160170180190200
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Figure B.18. 1H NMR of Benzyl 3-(5-methyl-3,6-dioxo-1,4-dioxan-2-yl)propanoate (3). Spectrum contains residual EtOAc (4.1, 2.0, 
and 1.3 ppm). 
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Figure B.19. 13C NMR of Benzyl 3-(5-methyl-3,6-dioxo-1,4-dioxan-2-yl)propanoate (3). 
255075100125150175200
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Figure B.20. 1H NMR of (S,S)-3,6-(Benzyloxymethyl)-1,4-dioxane-2,5-dione (2). 
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Figure B.21. 13C NMR of (S,S)-3,6-(Benzyloxymethyl)-1,4-dioxane-2,5-dione (2). 
255075100125150175200
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Figure B.22. 1H NMR of dibenzyloxy-substituted PLA copolymer 3. 
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Figure B.23. 13C NMR of dibenzyloxy-substituted PLA copolymer 3. 
255075100125150175200
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Figure B.24. 1H NMR of hydroxy-bearing PLA copolymer 4. 
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Figure B.25. 13C NMR of hydroxy-bearing PLA copolymer 4. 
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Figure B.26. 1H NMR of succinic anhydride-modified PLA copolymer 5. 
1.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0
 182
 
 
Figure B.27. 13C NMR of succinic anhydride-modified PLA copolymer 5. 
255075100125150175200
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Figure B.28. 1H NMR of cinnamate-modified PLA copolymer 5. 
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Figure B.29. 13C NMR of cinnamate-modified PLA copolymer 5. 
255075100125150175200
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Figure B.30. 1H NMR of hydroxyl-terminated PNb macroinitiator. 
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Figure B.31. 13C NMR of hydroxyl-terminated PNb macroinitiator. 
255075100125150175200
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Figure B.32. 1H NMR of PNb-bl-PLA diblock copolymer. 
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Figure B.33. 13C NMR of PNb-bl-PLA diblock copolymer. 
255075100125150175200
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Figure B.34. 1H NMR of hydrogenated PNb-bl-PLA diblock copolymer. 
0.51.01.52.02.53.03.54.04.55.05.56.06.57.07.58.0
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Figure B.35. 13C NMR of hydrogenated PNb-bl-PLA diblock copolymer. 
255075100125150175200
 
 191
0.6
0.7
0.8
0.9
1
1.1
5001000150020002500300035004000
Wavenumbers (cm-1)
T
r
a
n
s
m
i
t
t
a
n
c
e
 
 
Figure B.36. ATR-IR spectra of (S,S)-3,6-(Benzyloxymethyl)-1,4-dioxane-2,5-dione (2). 
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Figure B.37. ATR-IR spectra of dibenzyloxy-substituted PLA copolymer 3. 
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Figure B.38. ATR-IR spectra of hydroxy-bearing PLA copolymer 4. 
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Figure B.39. ATR-IR spectra of succinic anhydride-modified PLA copolymer 5. 
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Figure B.40. ATR-IR spectra of cinnamate-modified PLA copolymer 5. 
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